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Summary 
CyFIP (Cytoplasmic Fragile X mental retardation protein Interacting Protein) is a large 
scaffolding protein that was shown to be a central regulatory component of the WAVE 
complex. The pentameric WAVE complex is a nucleation promoting factor (NPF) 
regulated by phosphoinositides and phosphorylation, which translates signals from the 
small GTPase Rac1 by exposing the VCA domain in the WAVE subunit, thus activating 
the Arp2/3 actin nucleation complex and initiating actin polymerization. Actin 
reorganization is important for cell motility, migration, locomotion, proliferation and 
more. Except for HSPC300/Brick, each subunit is represented by a gene family - 
CyFIP1 and CyFIP2 for CyFIP, Nap1/Hem2 and Hem1 for Nap, WAVE1, WAVE2, and 
WAVE3 for WAVE, and Abi1, Abi2, and Abi3 for Abi. In principle this allows to build 
many different WAVE complexes, a few of which have also been crystalized and their 
structure determined. Despite the extensive sequence similarity, the expression 
pattern of CyFIP1 and CyFIP2 in mouse tissues suggests distinct physiological roles. 
CyFIP1 is ubiquitously expressed, while CyFIP2 has a more specialized function in the 
nervous system, where it is ten-fold more abundant than its homologue. CyFIP1 has 
been proposed to function as a tumor suppressor gene and is a known interaction 
partner of FMRP in the brain (Fragile X Mental Retardation Protein), hence having a 
distinct role in translational control. CyFIP1 has also been linked to autism spectrum 
disorder phenotypes in Prader-Willi, Angelman and Fragile X Syndromes. 
In this work the role of CyFIP1 during mouse embryonic development, ES cells in vitro 
differentiation and female fertility was analyzed, as well as the composition of the 
WAVE complex. The results showed that CyFIP1 has an essential role in early 
embryonic development and CyFIP1-/- embryos die around embryonic day 6.5. To 
obtain better insight into the function of CyFIP1 in development two strategies were 
used: 1. analysis of the embryos and 2. Generation and differentiation of ES cells. 
Generated CyFIP1-/- ES cells showed disturbed cell proliferation, differentiation and 
adhesion. Differentiation studies of CyFIP1-/- ES cells into embryoid bodies (EB) 
indicated that lineage determination is altered. EBs showed an increase in endodermal 
tissue, a decrease in meso-endodermal tissue and higher apoptosis. Importantly ES 
cells showed alterations in the levels of several WAVE complex components. 
Microarray analysis of in vitro differentiated ES cells revealed down-stream effectors 
and pathways affected by CyFIP1 depletion. 
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CyFIP1+/- females showed an infertility disorder similar to women with Fragile X-
dependent POI (primary ovarian insufficiency) Syndrome. Investigations in the ovaries 
and follicles of wild type and CyFIP1+/- females showed some important differences. 
Altered follicle distribution in the ovaries of CyFIP1+/- females was observed. Antral 
and preovulatory follicles of CyFIP1+/- females appeared significantly smaller than wt. 
Studies on the ligands and composition of the WAVE complex indicated that the WAVE 
complex is not an irreversibly stable pentameric complex. Biochemical analyses under 
different ionic conditions were made and results are in agreement with the predictions 
from the structure determined by the Rosen lab, showing how CyFIP/Nap forms a core 
complex around which the other subunits assemble. Variable complexes were 
recognized in different tissues. Novel Cyfip1/2 ligand candidates were identified by 
mass spectrometry after pull-down of the complex in brain, such as Cofilin1, CapZ, 
Myosin1 and Myosin4. One surprising novel Cyfip1/2 ligand was POF1 (Premature 
ovarian failure 1B), an actin binding protein mutated in human premature ovarian 
failure. These latest findings expand the current view of the WAVE complex. 
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1.1 The actin cytoskeleton 
The term cytoskeleton was first introduced by the French embryologist Paul Wintrebert 
in 1931. The cytoskeleton is composed of three major types of protein filaments: 
microtubules, intermediate filaments, and microfilaments. Microfilaments are polymers 
of actin that together with a large number of actin-binding and associated proteins 
constitute the actin cytoskeleton. Actin genes have been highly conserved during 
evolution, and actin molecules from various organisms are functionally 
interchangeable in vitro (Kron, Drubin et al. 1992; Nefsky and Bretscher 1992). Actin 
is a 42 kDa ATPase that can polymerize into filaments of 7 nm in diameter. Two 
different actin forms exist. G-actin is the monomeric form and F-actin is the polymeric 
form of actin. Globular (G) actin is able to polymerize into filamentous (F) actin which 
can disassemble back into the initial G-actin. Actin filaments are very dynamic and live 
in permanent reorganization. ATP-bound G-actin assembles into the filament. Upon 
binding to the end of a filament, an actin subunit rapidly hydrolyzes its bound ATP into 
ADP and a phosphate group (Pi) that is slowly released (Fig. 1). ADP-bound actin is 
prone to depolymerization. Released ADP-G-actin is recharged with ATP and ATP-G-
actin is able to bind again. ATP-actin subunits preferentially bind to the fast growing 
"barbed" end of an actin filament (Fig. 1), although they can also bind on the other side, 
to the "pointed" end, at a much slower rate. In the cell, several actin binding proteins 
act together to control the polymerization process, which is directed towards the cell 
membrane. 
 
 
 
 
 
 
Figure 1: Actin polymerization and 
depolymerization.  
Continuous remodeling of the actin 
filament at the fast growing barbed end 
and slow growing pointed end (Kuhn and 
Pollard 2005). 
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1.2 Actin binding proteins 
Actin filaments play a crucial role in different processes such as cell migration, motility, 
intracellular trafficking and cell division. All of these are dynamic processes that require 
polarity and a continuous reorganization of the actin filament network. In cells, the 
assembly and disassembly of actin filaments, and also their organization into functional 
higher order networks, is regulated by a plethora of actin-binding proteins (ABPs) (dos 
Remedios, Chhabra et al. 2003). The activities of these proteins are in turn under the 
control of specific signaling pathways. They have the following functions: nucleation, 
monomer binding, capping, stabilization, severing, depolymerization, cross-linking, 
sequestration, and nucleotide exchange. In Fig. 2 the different classes of actin binding 
proteins are shown.  
 
 
Figure 2: The actin cytoskeleton is regulated by actin-binding proteins (ABPs). Different classes of ABPs are 
shown (Winder 2005). 
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1.3 Profilin 
Profilin is one of the first characterized actin binding proteins and is involved in the 
dynamic turnover and restructuring of the actin cytoskeleton (Carlsson, Nystrom et al. 
1977). Profilin forms a 1:1 complex with G-actin and, acting as an ADP-ATP exchange 
factor, can regulate the rate of actin polymerization (Mockrin and Korn 1980). Today 
four Profilin genes are known in mice and humans (Kwiatkowski and Bruns 1988; 
Honore, Madsen et al. 1993; Braun, Aszodi et al. 2002; Obermann, Raabe et al. 2005). 
Profilin 1 and 2 are described to play a major role in actin dynamics. In mice Profilin1 
is expressed ubiquitously, except in the skeletal muscle. The deletion of Profilin1 in 
mice results in lethality before the blastocyst stage due to a possible defect in 
cytokinesis (Witke, Sutherland et al. 2001). Profilin2 is mostly expressed in brain, 
although lower expression can be found in skeletal muscle, testis, uterus, thymus and 
kidney. Two splice variants, Profilin2A and Profilin2B, have been reported (Witke, 
Podtelejnikov et al. 1998; Di Nardo, Gareus et al. 2000). A knockout study of this gene 
in mice described neurological and behavioral defects (Pilo Boyl, Di Nardo et al. 2007). 
Profilin1 and Profilin2 form different complexes to regulate actin assembly (Witke 
2004). Among others, one of the ligands in the Profilin2 complex is POP (Partner of 
Profilin) (Witke, Podtelejnikov et al. 1998), also named CyFIP, whose study is the main 
topic of this thesis. 
 
 
1.4 Actin nucleators and nucleation promoting factors 
Actin nucleators promote the polymerization of the different types of actin arrays 
formed in a variety of cellular processes, such as cell migration, cell division, cellular 
morphogenesis, and membrane trafficking. The first discovered actin nucleator was 
the Arp2/3 (actin-related protein 2/3) complex (Machesky, Atkinson et al. 1994; Mullins, 
Stafford et al. 1997). In the last decade the complexity of nucleation mechanisms 
became clear and several novel nucleators have been described. Today about 28 
different nucleators are known in mammalian cells. These can be divided into three 
Classes (Fig. 3): (1) the Arp2/3 complex and its nucleation promoting factors (the 
WASP and the WAVE families), (2) formins, and (3) WH2-containing nucleators like 
Spire, Cobl, and Leiomodin. 
1. Introduction 
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WASP family members use their WH2/V (Wiskott-Aldrich homology 2/Verprolin 
homology) domain to recruit actin monomers and their cofilin homology (C) and acidic 
(A) domains to bind to one subunit of the actin-related protein 2/3 (Arp2/3) complex. 
This structure, created and stabilized by N-WASP, mimics an actin trimer and allows 
further addition of actin monomers (Takenawa and Miki 2001). Arp2/3 also allows the 
formation of branched actin networks (Fig. 3) (Mullins, Heuser et al. 1998). Formins 
are hypothesized to nucleate actin by stabilizing spontaneously formed actin dimers 
and/or trimers. Differently from the Arp2/3, formins remain associated with the barbed 
end while favouring addition of actin subunits, thus functioning also as elongation 
factors for the formation of long linear filaments (Fig.3) (Faix and Grosse 2006). Spire, 
Cobl, and Lmod contain between one and four WH2 domains each, separated by 
intervening linker sequences of variable length (Kerkhoff 2006). Their nucleation 
mechanisms are related, but each may generate an actin nucleus with distinct 
properties (Fig. 3), stabilized by lateral and/or longitudinal contacts between subunits, 
and in some cases capped at one end. In some respects, N-WASP represents a 
specialized form of Class 3 nucleator, in which the third actin monomer-binding domain 
has been replaced with a domain that binds to actin-related proteins (Chesarone and 
Goode 2009). 
 
 
 
Figure 3: Mechanisms of actin nucleation. The three classes of actin nucleators and their mechanism of 
function are schematically represented. Nucleator domains are displayed in color, actin subunits used by 
nucleators to seed polymerization in black, and actin subunits polymerized from nuclei in gray (Chesarone and 
Goode 2009). 
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1.5 The Wiskott-Aldrich Syndrome protein (WASP) family 
WASP has been associated with modulation of lymphocyte activation and cytoskeletal 
reorganization (Aldrich, Steinberg et al. 1954; Cooper, Chae et al. 1968). Indeed the 
Wiskott-Aldrich syndrome, an X-linked recessive disease, is characterized by 
immunodeficiency, thrombocytopenia and eczema (Thrasher 2002). Five proteins 
belong to this protein family: WASP, N(neural)-WASP, WAVE1, WAVE2 and WAVE3. 
WASP is only present in cells from the hematopoietic system. N-WASP shares 
sequence homology with WASP and shows a high expression in the nervous system 
(Miki, Miura et al. 1996). WAVE is the acronym of WASP-family Verprolin-homologous 
protein (Suetsugu, Miki et al. 1999). The three mammalian WAVE isoforms have 
different expression pattern. WAVE1 and WAVE3 are highly expressed in the brain, 
WAVE2 is ubiquitously expressed (Takenawa and Miki 2001). All WASP family 
members share a common C-terminal organization, the VCA region. The VCA region 
consists of three domains: the Verprolin homology domain (V), also known as WH2 
(WASP Homology 2) domain, the cofilin homology or central domain (C), and the acidic 
domain (A). The N-terminus is similar in WASP and N-WASP with the WH1 (WASP 
Homology 1) domain and the autoinhibitory domain. WAVE proteins, instead, have a 
WHD (WAVE Homology Domain) also called SCAR homology domain (SHD) (Bear, 
Rawls et al. 1998). WASP and N-WASP possess a GTPase-binding domain (GBD), 
which can bind directly to the small GTPase Cdc42. Cdc42 regulates filopodia 
formation activating WASP/N-WASP which recruit and activate the Arp2/3 complex, 
triggering actin polymerization (Miki, Sasaki et al. 1998). WAVE proteins are also 
downstream of a small GTPase, called Rac1, but they have no possibility for a direct 
interaction with it, missing the GBD. Other proteins have been found to interact with 
WAVE and respond to Rac1 signaling, organized in the so called WAVE complex 
(Eden, Rohatgi et al. 2002). 
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1.6 The WAVE complex 
The WAVE complex is formed as a heteropentamer of a molecular weight of about 500 
kDa (Eden, Rohatgi et al. 2002). The components of the WAVE complex are WAVE 
itself, Abi (Abelson-interacting protein), Nap (Nck-associated protein), CyFIP 
(cytoplasmic Fragile-X mental retardation-protein interacting protein) and HSPC300 
(heat-shock protein C300, also known as Brick) (Eden, Rohatgi et al. 2002). As 
previously mentioned, there are three WAVE isoforms in mammals, WAVE1 and 
WAVE2 have been reported to be part of the WAVE complex. Later studies on WAVE3 
showed that WAVE3 is likely to participate in similar signaling complexes to WAVE1 
and WAVE2 and that the differences between these WAVE proteins are likely to be at 
the level of tissue expression, differences in affinity for certain binding partners and 
possibly interaction with yet undiscovered binding partners (Stovold, Millard et al. 
2005). The Abi family also comprises three different isoforms: Abi1, Abi2 and Abi3 
(Nesh). All three can be part of the WAVE complex, but Abi3 likely plays a different 
role in the regulation of c-Abl (Hirao, Sato et al. 2006). Abi is a scaffolding molecule 
that was originally identified as an interactor for the tyrosine kinase Abl (Shi, Alin et al. 
1995). Nap1 or p125Nap was reported to bind the SH3-containing protein Nck. In 
hematopoietic cells a different isoform is expressed called Hem1. CyFIP is the direct 
interaction partner of Nap1 in the WAVE complex (Fig. 4) and two isoforms exist 
(CyFIP1 and CyFIP2). HSPC300 is the smallest subunit of the WAVE-complex, a small 
peptide of approximately 75 amino acids whose function is still unclear. 
The exact architecture of the WAVE complex was identified by Chen et al. in 2010 and 
is schematized in Figure 4. The WAVE complex consists of two sub-complexes: a 
dimer formed by pseudo-symmetric association of the two large, similar proteins CyFIP 
and Nap1, and a trimer formed by the N-terminus of WAVE1, Abi2 and HSPC300 
forming a four-helix bundle.  
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Figure 4: Structure and composition of the WAVE complex. A) Topography as determined by biochemical 
studies (Adapted by Marzia Massimi from Gautreau 2004). B, C) CyFIP/Sra1 and Nap1 build the base of the 
complex as a pseudo-symmetric dimer. WAVE, Abi and HSPC300 form a trimer that lies on top of the base. In 
case of the inactive form, Nap1 keeps the VCA region of the WAVE protein inaccessible to possible binding 
partners. Following activation by the Rac1 small GTPase this region is exposed B) Stereo view of the WAVE-
complex. Sra1, Nap1, WAVE1, Abi2 and HSPC300 are green, blue, magenta, orange and yellow, respectively. 
C) 180° rotation around a horizontal axis of the structure in A). The polybasic region and the proposed Rac1 and 
eIF4E binding sites are indicated. (Chen, Borek et al. 2010) 
 
 
1.6.1 Regulation of the WAVE complex 
The WAVE complex plays an essential role in remodeling the actin cytoskeleton. The 
complex is by default inactive towards the Arp2/3 complex, but can be stimulated by 
the Rac1 GTPase, kinases and phosphatidylinositols. Within the structure of the 
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regulatory WAVE complex, the activity of WAVE toward the Arp2/3 complex is inhibited 
by intra-complex sequestration of its VCA region (Chen, Borek et al. 2010). In fact, the 
WAVE proteins lack the auto-inhibition feature. Therefore it depends on the other 
components of the WAVE complex fulfilling the inhibitory function. This is achieved 
through the structure of the complex. The inactive form of the complex shows WAVE’s 
VCA region facing Nap1, which makes it unreachable to possible binding partners (Fig. 
5). The regulatory WAVE complex is recruited to the membrane and triggered by 
extracellular signals to release its inhibition of WAVE (Padrick, Cheng et al. 2008; 
Lebensohn and Kirschner 2009). Activation of the WAVE complex is achieved by the 
small GTPase Rac1 (Fig. 4), which directly interacts with CyFIP1, or might act through 
a yet unknown mediator, by exposing the VCA domain (Goley and Welch 2006). The 
VCA region of the WAVE protein is responsible for the binding of Actin monomers and 
the Arp2/3 complex. The Arp2/3 complex, as previously explained, an important F-
actin nucleator, is therefore recruited by the WAVE protein to finally trigger actin 
polymerization via a tripartite complex formed close to the cell membrane (Fig. 4) 
(Bogdan, Grewe et al. 2004).  
However, the exact composition of the WAVE complex and the complexity of its 
regulation and function in vivo and in the different cell types and tissues remain still 
unclear. 
 
Figure 5: WAVE complex activation. Model of WAVE complex activation according to the Chen&Rosen 
structure (Chen, Borek et al. 2010). Activated Rac1, phosphorylation, and phospholipids are thought to unmask 
the VCA domain required for Arp2/3 activation (adapted from Stradal et al., TICB, 2004). 
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1.6.2 Genetics of the WAVE complex in the mouse 
In the past years several studies on knockout mice for the different subunits of the 
WAVE complex have been published. There are three different studies on WAVE1 
knockout mice, which were generated with two different methods. In the studies from 
Dahl et al. a gene trap approach was used to generate a line of mice bearing a 
disruption of the WAVE1 gene. Homozygous disruption of the WAVE1 gene resulted 
in postnatal lethality at day 20. These animals showed severe limb weakness, a resting 
tremor, and notable neuroanatomical malformations without overt histopathology of 
peripheral organs (Dahl, Wang-Dunlop et al. 2003). The same WAVE1 knockout mice 
were used for another study that described defects in myelin formation (Kim, 
DiBernardo et al. 2006). A different targeted disruption of the WAVE1 gene by 
homologous recombination generated viable mice with reduced anxiety, sensorimotor 
retardation, and deficits in hippocampal-dependent learning and memory (Soderling, 
Langeberg et al. 2003). WAVE2 knockout mice were created similarly by homologous 
recombination in one study that reported embryonic lethality at E12.5, with defects in 
the response of fibroblasts to platelet-derived growth factor (Yan, Martinez-Quiles et 
al. 2003). Another study on a different WAVE2 knockout model showed embryonic 
cardio-vascular defects, hemorrhages, and lethality at about embryonic day 10. Mutant 
endothelial cells did not form lamellipodia in response to VEGF (vascular endothelia 
growth factor) (Yamazaki, Suetsugu et al. 2003). One conclusion from these knockout 
studies could be that WAVE1 and WAVE2 have overlapping functions during early 
embryo development because both single mutants survive midgestation (Soderling, 
Langeberg et al. 2003; Yamazaki, Suetsugu et al. 2003; Yan, Martinez-Quiles et al. 
2003). WAVE3 and HSPC300 knockout mice are not described yet. Abi1 knockout 
mice died around embryonic day 11.5 and displayed malformations in the developing 
heart and brain. Western blotting analysis of Abi1 ko cell lysates indicated decreased 
levels of WAVE2 complex components: WAVE2, Nap1, and CyFIP1. On the contrary, 
the expression of Abi2 was significantly increased. Apparently the presence of Abi1 is 
critical for the integrity and stability of the WAVE2 complex so that it cannot be restored 
even by enhanced Abi2 expression (Dubielecka, Ladwein et al. 2011). Homozygous 
deletion of the murine Abi2 gene in mice resulted in defective orientation and migration 
of secondary lens fibers, abnormal neuronal migration in the neocortex and 
hippocampus, aberrant dendritic spine morphology and density, and profound deficits 
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in learning and memory (Grove, Demyanenko et al. 2004). Two different Nap1 
knockout mouse models are reported in the literature. In Nap1 ko mice, generated by 
insertional mutagenesis in the C-terminal region of the gene, embryonic lethality at 
E10.5 was observed, with several morphogenetic defects, such as strikingly open, 
undulating neural folds in the anterior of the embryo (Yokota, Ring et al. 2007). A 
different Nap1 mutant mouse model was generated by a missense mutation by ENU 
(N-ethyl-N-nitrosourea) mutagenesis at the beginning of the Nap1 coding sequence. 
These Nap1 knockout mice arrested embryonic development around day E9 and 
displayed several morphogenetic defects such as delay in endoderm and mesoderm 
migration, failure in heart formation and neural tube closure, duplication of the antero-
posterior body axis. Interestingly, loss of Nap1 induced loss of WAVE1 expression and 
cellular mislocalization of Abi1 and CyFIP1/Sra1 (Rakeman 2006).  
 
 
1.7 CyFIP 
From previous work, CyFIP appears to have many functions and interacting partners, 
some of which are known and some might still be unknown. Due to this, CyFIP was 
given a number of names. In 1998 CyFIP was described under the name p140Sra1. It 
was purified from bovine brain cytosol and identified as a 140 kDa molecular mass 
Rac1-interacting molecule. Therefore it was named Specifically Rac-associated 
protein 1 (p140Sra1) (Kobayashi, Kuroda et al. 1998). At the same time CyFIP was 
found as an interactor of Profilin2 and named POP (Partner of Profilin) (Witke, 
Podtelejnikov et al. 1998). The name PIR121 (121F-specific p53-inducible RNA) was 
given in a work in which the level of a specific messenger RNA, identified as the CyFIP 
mRNA, was found increased in cell lines expressing the apoptosis-inducing p53 
mutant, 121F (Saller, Tom et al. 1999). PIR121 is normally used for the Dictyostelium 
orthologue. Another name for CyFIP, derived from a work on a C. Elegans mutant 
phenotype, is Gex2 or Gut on the Exterior 2 (Soto, Qadota et al. 2002). Finally, the 
name CyFIP1 and 2 (Cytoplamic FMRP Interacting Protein) was given in 2001 when a 
yeast two-hybrid screening yielded two novel interactors of FMRP (Schenck, Bardoni 
et al. 2001). Related to this, a novel role for CyFIP1 was recently reported, that might 
be independent from its role in the WAVE complex. CyFIP1 can behave as an eIF4E 
inhibitor, a novel 4E-BP (eukaryotic translation initiation factor 4E Binding Protein), 
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cooperating with FMRP in down-regulating translation in neurons (Napoli, Mercaldo et 
al. 2008). In lower organisms only one CyFIP gene is present, while in human and 
mouse two genes, encoding for CyFIP1 and CyFIP2, are found. In the mouse these 
genes are located on chromosome 7 and 11, respectively, showing the same genomic 
organization of 31 exons encoding for 1253 amino acids. CyFIP1 and 2 share 88% 
amino acid sequence identity and have the same molecular weight of 145 kDa. In the 
mouse CyFIP2 was shown to be approximately 10 fold more abundant in brain than 
CyFIP1 at the mRNA level (Massimi 2008). CyFIP1 is the predominant isoform 
expressed in ES cells and early embryonic stages, while CyFIP2 is expressed later 
during development and then restricted to the brain (Massimi 2008), but the specific 
role of CyFIP1 in development is still unknown.  
 
1.7.1 The physiological role of CyFIP1 and CyFIP2 
Several studies have been carried on model organisms such as Dictyostelium, C. 
Elegans, and Drosophila and also on different cell types in order to understand the 
physiological role of CyFIP. In Dictyostelium the pirA gene which encodes 
PIR121/CyFIP was disrupted and defects in migration and chemotaxis were observed 
(Blagg, Stewart et al. 2003). Ablation of the worm gene Gex2 resulted in embryonic 
lethality with defects in morphogenesis of the hypodermis. In Gex2 mutants, neither 
dorsal intercalation nor ventral migration (including leading cell migration) occurred, 
resulting in the complete loss of ventral closure (Soto, Qadota et al. 2002). Drosophila 
Sra1 null mutants were also embryonic lethal and showed defects in synaptic 
architecture and bristle development (Schenck, Bardoni et al. 2003; Bogdan, Grewe et 
al. 2004). Studies in zebrafish showed that CyFIP2 is required to maintain positional 
information by dorso-nasal axons as they project through the optic tract and the tectum 
(Pittman, Gaynes et al. 2010). Bozdagi et al. showed that haploinsufficiency of CyFIP1 
mimics key aspects of the phenotype of Fmr1 knockout mice and is consistent with the 
hypothesis that these effects are mediated by interaction of CyFIP1 and FMRP in 
regulating activity-dependent translation. They observed that in CyFIP1 heterozygous 
mice metabotropic glutamate receptor (mGluR)-dependent long-term depression 
(LTD) induced by paired-pulse low frequency stimulation (PP-LFS) was significantly 
increased in comparison to wildtype mice. In addition, mGluR-mediated LTD was not 
affected in the presence of protein synthesis inhibitors in the CyFIP1 heterozygous 
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mice, while the same treatment inhibited LTD in wildtype littermate controls. Behavioral 
studies of CyFIP1 heterozygous mice showed enhanced extinction of inhibitory 
avoidance (Bozdagi, Sakurai et al. 2012). In mammalian cell culture studies, using 
siRNA, CyFIP1 was shown to be essential for lamellipodia formation and the entire 
WAVE complex could no longer be detected in CyFIP1 knockdown cells (Steffen, 
Rottner et al. 2004).  
 
1.7.2 CyFIP1 knockout mouse 
A CyFIP1 conditional knockout mouse was generated by Dr. Marzia Massimi in a 
C57BL/6J mouse genetic background. The targeting vector carrying the CyFIP1 
genomic sequence and LoxP sites flanking exon 4 and exon 6, together with a 
Neomycin resistance cassette, was created as shown in Fig. 6. Excision of the LoxP 
flanked region upon Cre recombination resulted in a frame shift leading to premature 
translation termination soon after exon 3, producing a knockout allele. The Neomycin 
resistance cassette was also flanked by FRT sites, which allowed its removal upon 
FLP recombination (Massimi 2008) to produce a clean Flox allele. 
 
 
 
Figure 6: CyFIP1 targeted allele and the Cre-mediated recombination event leading to the CyFIP1 
knockout allele. Exon 4 and exon 6 are flanked by LoxP sites. These can be used for the conditional removal 
of the flanked region by Cre recombination. A Neomycin resistance cassette, flanked by FRT sites, was also 
inserted for the selection of recombinant ES cell clones. The Neomycin cassette can be removed by FLIP 
recombination (Massimi 2008). 
 
To generate the CyFIP1 complete knockout mouse, CyFIP1+/targeted mice were 
crossed with a Cre-deleter strain. Heterozygous CyFIP1 deleted mice (CyFIP1+/-) 
were then mated among themselves to obtain CyFIP1 null mutants (CyFIP1-/-). The 
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CyfFIP1 complete knockout resulted embryonic lethal, with embryos dying around 
embryonic day 8.5 due to severe developmental defects (Fig. 7). Somites were absent 
in the mutant embryos and the tissues appeared to be degraded. Some components 
of the WAVE complex were no longer detectable in homozygous CyFIP1 ko embryos 
by Western blotting (Massimi 2008). The generation of the conditional CyFIP1 mouse 
model is still in progress. 
 
   
   
 
Figure 7: CyFIP1 null mutants and control littermates. (A) E8.5 CyFIP1-/- embryo. (B) E8.5 CyFIP1+/+ 
embryo that has started to differentiate the neural plate (indicated by an arrow). (C) E9 CyFIP1-/- embryo. 
(D) E9 CyFIP1+/+ embryo. The differences between mutant and wild type are more evident at this stage: it 
is evident the lack of differentiated somites in the mutant, while in the control 6 pairs of somites are visible. 
(E) E9.5 CyFIP1-/- embryo. (F) E9.5 CyFIP1+/+ embryo. Only a few mutants reached this stage, had an 
overall degenerated aspect, and their tissues appeared degraded (Massimi 2008). 
 
1.7.3 CyFIP1 in Autism Spectrum Disorders 
In humans, CyFIP1 has been genetically linked to a number of Autism Spectrum 
Disorders (ASDs), which suggests that CyFIP1 might be a central component of the 
different ASD pathways. The CyFIP1 gene in humans is located on chromosome 
15q11.2, this is a critical region of high susceptibility to deletion and duplication 
(Pathania, Davenport et al. 2014). For example paternal or maternal deletion occurs in 
the Prader-Willi and Angelman Syndromes, respectively. The CyFIP1 gene falls within 
the range of chromosomal deletion responsible for the syndromes (Ben-Shachar, 
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Lanpher et al. 2009), and if included in the deletion increases the occurrence of the 
autistic phenotype in the syndromes. CyFIP1 has also been implicated in the autistic 
phenotype of patients with Fragile X syndrome (Clifford, Dissanayake et al. 2007). 
Apart from point mutations, gene dosage and copy number variation also play an 
important role in autism spectrum disorder (Nishimura, Martin et al. 2007). Two 
pathways that affect the maturation of excitatory synapses and therefore disrupt 
neuronal connectivity were shown to be affected by CyFIP1: the protein translation 
pathway (FMRP, PTEN and TSC1/2) and the actin cytoskeletal/adhesion molecule 
pathway (e.g Neuroligins, Neurexins, Shank and Integrin-β3) (Walsh, Morrow et al. 
2008). 
 
1.7.4 POF/POI (Premature Ovarian Failure / Premature Ovarian 
Insufficiency)  
Besides the neurological syndromes, CyFIP1, through one of its ligands, might be 
indirectly involved in another disease affecting the reproductive system. Studies have 
suggested that females who show premature ovarian insufficiency of unknown cause 
have a 1/50 chance of being a premutation carrier of the FMR1 gene, the same gene 
that causes Fragile X syndrome (Macpherson, Murray et al. 1999) and whose protein 
product FMRP is a well-known binding partner of CyFIP1. Females who have 
premature ovarian insufficiency have problems with ovarian function which can lead to 
infertility and early menopause. Indeed, two chromosomal regions involved in POF 
have been located on the long arm of the X chromosome at Xq13-21 (Omim: POF2) 
and at Xq26-28 (Omim: POF1) (Ennis, Ward et al. 2006) and FMR1 is found at Xq27.3. 
Blood testing of affected females showed high levels of the pituitary hormone FSH 
(follicle stimulating hormone) and low levels of the ovarian hormone AMH (anti-
Müllerian hormone). Recent studies suggest that the FMR1 gene can exert controlling 
functions on ovarian recruitment and ovarian reserve (Gleicher and Barad 2010). While 
POF has not been studied yet in FMR1 ko mice, in other studies germ cell deficient 
(gcd) mice were generated, which reproduced premature ovarian failure. Germ cell 
deficient mice underwent normal puberty and complete sexual development but by 6-
8 weeks of age their estrous cycle became irregular. Mice aged 12-16 weeks became 
reproductively senescent, as defined by the apparent absence of estrous cycling. The 
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ovaries of wild type mouse feature white spots that correspond to corpora lutea, while 
the ovaries of the germ cell deficient mice were much smaller with no gross evidence 
of ovarian activity (Duncan, Cummings et al. 1993).  
 
 
1.8 Ovarian and follicular development  
The mouse ovary is a very complex structure with tight regulation machineries between 
the different cell types. At birth, the ovary is a solid organ. It consists of only two 
different cell types: the oocytes and the stroma cells. Then the ovary undergoes 
massive changes in morphology in the five to eight weeks between birth and fertility. 
While the oocytes grow, the stroma cells differentiate into theca cells, lutein cells, 
granulosa cells and many others. The granulosa cells surround the oocytes, and form 
follicles that grow and differentiate while in constant interplay with the oocyte (Eppig 
2001). The concept of a regulatory loop between oocyte and follicles was proposed by 
Eppig et al. in 2001. He showed that follicular cells maintain oocytes in meiotic arrest 
until the pre-ovulatory surge of gonadotropins and, at the same time, promote growth 
and maturation of the oocyte. On the other hand the oocyte is crucial for follicle 
formation, as well as for granulosa cell proliferation and differentiation. During the 
fertile life of a female a constant maturation of follicles and oocytes takes place, starting 
with recruitment of primordial follicles and going on to ovulation or atresia, programmed 
follicular death. A mature ovary is structured with a compact cortical layer, where the 
follicles are localized, and a loose medulla in the middle of the organ, where blood 
vessels and lymphatic vessels can be found (Figure 8). 
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Figure 8: Organization of a mouse ovary. H&E staining of a frozen section from an adult mouse ovary. 
Indicated in the figure are the compact outer layer (Cortex) containing the follicles (green arrows) and the medulla 
in the center of the organ, a loose structure dense with vessels (red arrows). 
 
1.8.1 Follicle development and classification of the developmental 
stages  
In mature ovaries all follicular developmental stages are present at the same time. 
Several classification systems for oocytes and follicles have been published in the past 
years. The classification proposed by Pedersen & Peters 1968 and adapted later by 
Myers et al. (2004) is shown in Figure 9. Myers et al. classification is marked in red in 
Figure 9. It is a more simplified system, and was used in this thesis for the analysis of 
the ovaries of CyFIP1 heterozygous mice. 
Three big groups of follicles, small, medium and large, are subdivided in different 
Types. In the group of small follicles, Type 1 and Type 2 consist of non-growing small 
oocytes with no or only few granulosa cells attached. Small follicles, but surrounded 
by a whole layer of squamous granulosa cells, were named Type 3a follicles. All these 
were also called primordial follicles, and form the pool from where growing follicles are 
recruited. After recruitment, the oocyte starts growing and the granulosa cells become 
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cuboidal and start to proliferate. Type 3b or primary follicles contain a growing oocyte 
with a single layer of granulosa cells. Follicles with more than one layer of cells around 
the growing oocyte are called secondary follicles (Types 4 to 5b).  
 
 
Figure 9: Classification of the different developmental stages of a follicle. Small follicles: bare oocyte (type 1 
and 2) and primordial follicle consisting of the oocyte and one layer of squamous granulosa cells (type 3). Medium 
follicles: primary follicle surrounded by one layer of cuboidal granulosa cells (type 3b); secondary follicle with two 
to five layers of granulosa cells (type 4 to 5b). Large follicles: early antral follicle with small dispersed cavities in the 
granulosa cell layers and a fully mature oocyte (type 6); antral follicle with a large antrum filled with follicular fluid 
(type 7); pre-ovulatory follicle with a large antrum and a ring of granulosa cells encircling the oocyte (type 8) 
(modified from (Pedersen and Peters 1968)). 
 
The transition from medium to large follicles is marked by the formation of cavities 
containing follicular fluid. Oocytes in large follicles are fully grown and meiotically 
competent, which means that they can resume meiosis after a gonadotropin surge. 
Type 6 or early antral follicles, sometimes called tertiary follicles, display scattered 
cavities with follicle fluid. In Type 7 or antral follicles one large cavity (antrum) is present 
and divides the granulosa cell types into two different classes: (1) the oocyte-
associated cumulus cells and (2) the follicle-associated mural cells. The last class of 
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follicles is the pre-ovulatory or type 8 follicles. Following a pre-ovulatory gonadotropin 
surge, the oocyte resumes meiosis and the cumulus cells start to express hyaluronic 
acid, leading to cumulus expansion and finally to ovulation. 
 
 
1.9 Embryonic stem cells 
A useful tool to study early mouse development is to culture and in vitro differentiate 
Embryonic Stem cells (ES cells). ES cells are derived from the inner cell mass of 
blastocysts (Evans and Kaufman 1981; Martin 1981) but can also be isolated from 8-
cell stage embryos (Wobus, Wallukat et al. 1991) or from morulae (Eistetter 1989). 
Under optimal conditions ES cells can be expanded almost indefinitely in cell culture. 
Furthermore, embryonic stem cells are pluripotent cells and thus are able to 
differentiate into cells of the three germ layers: mesoderm, endoderm, and ectoderm. 
ES cells can be cultured into so-called “embryoid bodies” (EBs) that represent 
aggregates of differentiating ES cells in non-adherent cultures and consist of a core of 
ectoderm, mesoderm and endoderm surrounded by visceral and parietal endodermal 
cells (Maye, Becker et al. 2000). Using this approach ES cells can be differentiated 
into cardiogenic (Wobus, Wallukat et al. 1991; Maltsev, Rohwedel et al. 1993; Maltsev, 
Wobus et al. 1994), myogenic (Rohwedel, Maltsev et al. 1994), adipocytic (Dani, Smith 
et al. 1997), chondrogenic (Kramer, Hegert et al. 2000), osteogenic (Hegert, Kramer 
et al. 2002), hematopoetic (Schmitt, Bruyns et al. 1991), insulin-producing (Schroeder, 
Rolletschek et al. 2006), epithelial (Bagutti, Wobus et al. 1996) and also neuronal 
(Fraichard, Chassande et al. 1995; Strubing, Ahnert-Hilger et al. 1995; Rujano, Pina 
et al. 2004) cell types. The differentiation of mouse ES cells into non-somatic germ 
cells including oocytes and sperm cells has also been done (Hubner, Fuhrmann et al. 
2003; Kehler, Hubner et al. 2005). During in vitro differentiation ES cells-derived cells 
differentially express developmentally regulated genes encoding transcription factors, 
enzymes, receptors or ion channels, mimicking expression patterns that are seen in 
vivo during embryo development (Wobus, Wallukat et al. 1991; Rohwedel, Maltsev et 
al. 1994; Guan, Rohwedel et al. 1999). 
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1.10 Embryoid bodies 
The name embryoid bodies was given to these cell aggregates due to their similarities 
to post-implantation embryos. Embryoid bodies are three-dimensional structures 
generated by the aggregation of pluripotent stem cells when they are cultured in the 
absence of feeder cells and on low attachment surfaces. It was shown in 1985 that 
mouse ES cells can form EBs in vitro (Doetschman, Eistetter et al. 1985). The 
morphogenic events in EBs mimic multiple aspects of the post-implantation mouse 
embryo, including primitive endoderm formation (Grabel and Casanova 1986; Shen 
and Leder 1992), germ layer differentiation (Keller 1995; Itskovitz-Eldor, Schuldiner et 
al. 2000), and epithelial to mesenchymal transition (Shukla, Nair et al. 2010). The 
process of cavitation in mouse embryogenesis has also been examined using EBs 
(Coucouvanis and Martin 1999; Maye, Becker et al. 2000). The specific mechanism of 
cavitation in developing embryos and EBs is thought to be regulated by programmed 
cell death induced by factors secreted by the visceral endoderm, and survival of cells 
based on basement membrane attachment (Coucouvanis and Martin 1995; 
Coucouvanis and Martin 1999). EBs can be formed using a variety of techniques, 
including hanging drop (Maltsev, Wobus et al. 1994), static suspension (Doetschman, 
Eistetter et al. 1985), semi-solid methylcellulose culture (Ling and Neben 1997; Dang, 
Kyba et al. 2002), and stirred-culture bioreactors (Gerecht-Nir, Cohen et al. 2004). 
Each system has specific advantages and disadvantages (Kurosawa 2007); for 
example, the hanging drop method is relatively controlled, but not suitable for 
producing large amounts of EBs, while static suspension is simple and scalable, but 
not well controlled. Rotary suspension culture provides a middle ground between 
hanging drop and static suspension, in that it produces EBs uniform in size and shape, 
yet with a high yield (Carpenedo, Sargent et al. 2007). Directed differentiation of EBs 
is most commonly accomplished through addition of soluble factors to the culture 
medium. Growth factors such as vascular endothelial growth factor (VEGF) (Nourse, 
Halpin et al. 2010), brain derived neurotrophic factor (BDNF) (Takaki, Nakayama et al. 
2006), basic fibroblast growth factor (bFGF) (Yamada, Kioussi et al. 1994), epidermal 
growth factor (EGF) (Kang, Cho et al. 2007), and platelet-derived growth factor (PDGF) 
(Kang, Cho et al. 2007) have been studied in the context of EBs differentiation. Other 
morphogens such as bone morphogenetic proteins (BMPs) (Bruce, Gardiner et al. 
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2007), Wnts (ten Berge, Koole et al. 2008) and retinoic acid (Bain, Ray et al. 1996) 
have also been assessed for directed EB differentiation.  
 
 
1.11 Embryonic development 
Since the CyFIP1 knockout mouse model is embryonic lethal, a detailed analysis of 
early embryonic developmental events is required in order to understand which is the 
cause of lethality and, subsequently, the role of CyFIP1 and the WAVE complex in 
developmental events. Early embryonic development can be divided into two phases, 
a preimplantation and a postimplantation phase. 
 
1.11.1 Preimplantation development 
Preimplantation development is characterized by a fast cell division process from a 
one-cell embryo to a blastocyst stage embryo and lasts 4-5 days in mice (Fig. 10). 
Early cellular doubling divisions occur without a perceptible increase in embryo size.  
The zona pellucida surrounds the embryo until implantation (Comiskey, Goldstein et 
al. 2003). Mammalian embryos need to establish a permanent connection to maternal 
tissues to grant nutrient and oxygen supply. Timing of implantation in the mouse is at 
around 4.5 days of embryonic development (E4.5). The E4.5 mouse blastocyst 
contains three cell types: epiblast, trophoblast and primitive endoderm. Lineage 
studies, mostly using chimeras and reconstituted blastocysts, have shown that the 
three cell types give rise to distinct tissues later in development (Rossant 1987). The 
primitive endoderm and the epiblast lineage are the major cell lineages which are 
important for gastrulation (Srinivas 2006). 
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Figure 10. Preimplantation embryo development. (A) Schematic view of the development of the 
preimplantation embryo in mice from day 0 (E0) to day 5 (E5.0) (Wang und Dey, 2006, modified by Wörsdorfer). 
(B) Light microscopy images of early embryonic development stages. IZM: inner cell mass, BZ: blastocoele, TE: 
trophectoderm, ZP: zona pellucida (Braude, Pickering et al. 2002, modified by Wörsdorfer) 
 
1.11.2 Postimplantation development 
The early postimplantation development involves dynamic processes resulting in 
dramatic rearrangements in the embryo. At around E5.0, soon after implantation, the 
early postimplantation mouse embryos are divided into two regions and display a 
proximal-distal body axis (Fig. 11A).  
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Figure 11. Early postimplantation development in the mouse. (A) At PrS/egg cylinder stage, the embryo 
consists of two cell layers, the epiblast (blue) and the surrounding Visceral Endoderm (VE, light green) and is 
characterized by a proximal-distal (PD) axis. The differentiation of VE cells at the distal tip of the embryo into 
DVE (Distal VE, bright green) marks the first visible sign of the forming asymmetry. (B) Just prior to the beginning 
of gastrulation, the DVE migrates anteriorly (becoming Anterior VE, AVE) and marks the future anterior pole of 
the embryo. On the opposite side, at the very proximal end of the embryonic region, the primitive streak (PS) 
forms. (C) Mesoderm (yellow) and Definitive Endoderm (DE, orange) are formed in the PS. The PS progresses 
further distally and the produced DE and Mesoderm migrate laterally. Mesoderm also expands into the 
extraembryonic region, to form the visceral yolk sac (VYS) mesoderm. (D) At the early head fold (EHF) stage, 
almost the entire VE region has been replaced by DE and the VE displaced towards the extraembryonic region. 
The ectoderm in the anterior is specified to become neuroectoderm and the head folds start to extrude. At the 
anterior end of the PS, the node (nd), an embryonic organizer region, has formed. (E) At E8.5, the head folds 
have formed and the ventral body side of the embryo begins to close and thereby the embryo will be incorporated 
into the VYS. The mesodermal derived allantois establishes a contact to the chorion. Abbreviations: al: allantois, 
AVE: anterior visceral endoderm, DE: definitive endoderm DVE: distal visceral endoderm, EHF: early head fold 
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This is the egg-cylinder stage of the mouse embryo, so called because of a cup shaped 
structure. About 20 to 24 hours later, at early streak stage (~E6.5), the body axis shifts 
from proximal-distal to anterior-posterior and the embryonic germ layers begin to form: 
this is the process of gastrulation (Beddington 1981; Tam and Beddington 1987) (Fig. 
11B,C). The initiation of gastrulation is indicated by the primitive streak (PS), a transient 
structure that is located in the posterior of the embryonic region. Through the primitive 
streak epiblast cells can flow and form mesoderm and definitive endoderm. These cells 
then migrate to their respective destinations in the embryonic, and in the case of early-
generated mesoderm, also into the extraembryonic region (Parameswaran and Tam 
1995) (Fig. 11D,E). In consequence of the cylindrical shape of rodent embryos, the 
early postimplantation embryo requires a rotation along the longitudinal (antero-
posterior) axis that results in an inversion of the order of the germ layers: in fact before 
E8.0 the endoderm forms the outermost and the ectoderm the innermost cell layer, 
while at E9.5 the endodermal layer is on the inside of the embryo and the ectoderm is 
on the outside (Kaufman 1992). The inversion occurs in concert with the closure of the 
ventral and parts of the dorsal body walls in order to form a closed primitive gut and 
neural tube, respectively, and is referred to as embryonic turning (Kaufman 1992). This 
turning happens between E8.5 and E9.5 and together with the ventral closure gives 
rise to the folding of the midline endoderm and results in arranging the primitive gut 
tube (Fig. 12). This also induces the fusion of the two lateral heart primordia, which 
have already formed by E7.5, and the complete enclosure of the embryo by the visceral 
yolk sac. The visceral yolk sac is composed of cells of the extraembryonic region, 
which are the extraembryonic visceral endoderm and the extraembryonic mesoderm 
(Kaufman 1992; Erlacher 2009).  
 
stage, emb: embryonic region, epc: ectoplacental cone, ES: early streak stage, ExE: extraembryonic ectoderm, 
exemb: extraembryonic region, hf: head fold, ht: heart, MS: mid streak stage, nd: node, PrS: pre-streak stage, 
PS: primitive streak, VE: visceral endoderm, VYS: visceral yolk sack (Kaufman 1992, modified by Erlacher). 
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Figure 12. Embryonic turning in 
the mouse embryo. During early 
postimplantation development, the 
mouse embryo exhibits an inversion 
of germ layers. Chordate 
development requires the turning of 
the embryo in order to establish the 
embryonic body plan. (A) At E8.5, the 
embryo exposes its ventral body side, 
consisting of endoderm, to the 
outside and starts to be enclosed in 
the VYS. (B) While the enclosure in 
the VYS proceeds, the caudal end 
begins to “roll” in an anticlockwise 
motion around the rostral part of the 
embryo. (C) At E9.0, the embryo is 
almost entirely enclosed within the 
VYS. (D) The turning process is 
completed at around E9.5, and the 
embryo has achieved the fetal 
position, which is typical in chordate 
embryos. Abbreviations: al: allantois, 
hd: head, hf: head fold, ht: heart, 
VYS: visceral yolk sac (Kaufman 
1992, modified by Erlacher). 
 
With the inception of gastrulation the basis for proper development of neural and head 
structures is already laid down. The anterior ectoderm is structured to form the 
prospective brain structures. At head fold stage (E8.0), the neuroectoderm can already 
be distinguished from close-by surface ectoderm and elevates into clearly visible head 
folds (resulting in the stage name). Between E8.0 and E9.5, the time of embryonic 
turning, the head folds and the more caudal neuroepithelium folds up. The folds close 
and fuse in an exactly regulated mode which is starting at the hindbrain level and 
continues both rostrally and caudally forming the future fore- mid- and hindbrain 
regions and the neural tube. Subsequently, the neural tube generates the spinal cord 
(Kaufman 1992). During further development, many different cell types, structures and 
organs are specified at their designated location. All developmental stages are subject 
to exact regulatory machineries, consisting of a large number of different gene 
products that are present at a given time in a certain environment (Erlacher 2009). 
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1.11.3 Theiler stages 
Theiler stages have been used for a more detailed classification of embryonic 
development than the normal “days post coitum” or “embryonic day” classification. The 
mouse development is divided into 26 prenatal and 2 postnatal Theiler stages. Each 
Theiler stage is identified with one 'average' age, and a range of variation of real ages, 
centered on this average, that can be seen when actual developing embryos are 
studied. In fact, embryos of the same gestational age may differ in their stage of 
development. Especially during preimplantation and early postimplantation 
development, the embryo is involved in dynamic processes and dramatically 
rearranged in one day, so that the Theiler stages can quantify these changes in a better 
way. Theiler's criteria are, for example, cell number or somite number and therefore 
allow to distinguish many of the important phases of early development. 
 
 
Figure 13. Theiler stages and their 
relationship to “days post-coitum” 
(dpc). The 25 Theiler stages and the 
corresponding development of the 
embryo are shown (Kaufman 1992) 
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1.12 Aim of the Thesis 
The aim of this thesis is to obtain better insight into the functions of CyFIP1 and the 
WAVE complex during oogenesis and early mouse development: how the actin 
nucleation function is reconciled with cellular events such as cell survival, apoptosis, 
membrane trafficking and cell lineage programming; how the composition of the WAVE 
complex is regulated and which could be the relevant upstream and downstream 
signaling pathways. 
The starting point was the observation that CyFIP1 heterozygous females showed a 
reduction of fertility at as early as 10-12 weeks of age. Therefore the role of CyFIP1 in 
ovarian and follicular maturation was analyzed. 
Previous studies showed that embryos lacking CyFIP1 die at E6.5. The role of CyFIP1 
and the WAVE complex was studied during early embryonic development by using the 
CyFIP1 knockout mouse model. A focus was put on the genetic background and 
mutation inheritance in the mouse. In parallel to the analysis of early mutant mouse 
development, CyFIP1 ko ES cells were employed in an in vitro paradigm of embryonic 
development, the embryoid bodies. In this in vitro model of development, cell 
proliferation, differentiation and adhesion were analyzed. Germ layer formation 
mimicked in the embryoid bodies approach was analyzed by flow cytometry using 
specific developmental markers.  
Finally, the complexity of the composition of the WAVE complex was studied and new 
possible ligands were identified with biochemical and spectroscopic methods.  
  
2. Material 
28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Material 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Material 
29 
 
2.1 General stock solutions, buffers and media 
 
2.1.1 General solutions 
Solution   Concentration Substance 
10x PBS (1l) 1.5 M (87.68 g)  
162 mM (23 g anhydrous) 
38 mM (4.56 g) 
pH 7.4 
 
NaCl 
Na2HPO4 
NaH2PO4 
PBT 0.1 % Tween-20  
in PBS 
 
4% Paraformaldehyde (100 
ml) 
60 ml 
4 g  
dissolve at 65 ºC  
adjust volume to 100 ml
  
sterile filtrate 
 
PBS 
PFA 
 
PBS 
TBS (1l 10x) 1.5 M (87.68 g) 
  
0.25 M (25 ml) 
  
NaCl  
(1 M) Tris/HCl pH 
7.4 
TBS-T 0.2%  Tween-20  
in TBS 
 
2.1.2 Solutions for the analysis of nucleic acids 
Solution Concentration Substance 
50x TAE-Buffer (1l) pH 8.3 2 M (242.2 g) Tris base 
 57.1 ml Glacial acetic acid 
 0,05 M (100 ml)  EDTA 0.5 M (pH 8,0) 
2. Material 
30 
 
Proteinase K (stock in H2O) 10 µg/µl  
   
Tail DNA extraction buffer 50 mM  Tris/HCl pH7.4 
 100 mM NaCl 
 1% SDS 
 5 mM EDTA 
 0.5 µg/µl Proteinase K 
   
ES cells DNA extraction buffer 20 mM  Tris/HCl pH7.4 
 150 mM NaCl 
 2 mM EDTA 
 1% SDS 
 0.5 μg/μl Proteinase K 
   
DNA loading buffer 40% Sucrose 
 0.5% SDS 
 0.25% Bromophenol blue 
   
DNA ladder 1 kb Plus (500 µl) 50 µ  DNA ladder 1 kb Plus  
 83 µl DNA loading buffer 
 367 µl H2O 
   
RNA lysis buffer 100mM 
10mM 
NaCl 
MgCl2l 
 5mM 
50mM 
1% 
EDTA 
Tris/HCl pH 7.4 
Triton-X100 
 40U/ml RNAseOut (added just prior 
to use) 
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2.1.3 Solutions and Media for ES cell culture 
Solution Concentration Substance 
ES cell medium 
(500 ml) 
410 ml 
15% (75 ml) 
1 mM (5 ml) 
1 mM (5 ml)  
10 mM (5 ml)  
1 mM (5 ml)  
5 ml 
4 µl 
1 ml 
DMEM medium 
ES cell-tested Fetal Calf Serum 
Non essential amino acids (100x stock) 
Sodium Pyruvate (100x stock) 
HEPES pH 7.2 (100x stock) 
Glutamine (100x stock) 
Pen/Strep antibiotics (100x stock) 
β-mercaptoethanol  
LIF conditioned media (contains leukemia 
inhibitory factor) 
 
ES cell 
differentiation 
medium 
  
ES cell medium without LIF and only 10% FCS 
ES cell freezing 
medium 
10% DMSO in ES cell medium 
 
 
Gelatine (0.2%) 0.2% (w/v) ‘Porcine skin gelatine’ 
  
2.1.4 Solutions and media for flow cytometry 
Solution Concentration Substance 
MACS buffer 2mM 
1% 
EDTA 
Fetal calf serum 
PBS 
 
0,1% 
1% 
TritonX  
Fish gelatine 
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2.1.5 Solutions for biochemical analysis 
Solution Concentration Substance 
Coomassie solution  50% 
10%  
0.1% 
 
 
Methanol 
Acetic acid 
Coomassie Brilliant Blue 
stir O/N, filtrate 
 
ECL solution A (200 ml) 0.1 M 
4 ml 
0.1 ml  
 
Tris/HCl pH 8.6 
Luminol stock 
P-hydroxy-coumarin stock 
 
ECL solution B (200 ml) 0.1 M 
0.2 ml 
Tris-HCl pH 8.6 
H2O2 (30%) 
 
Luminol stock solution (10 
ml) 
0.44 g Luminol  
in DMSO 
 
P-hydroxy-coumarin stock (1 
ml) 
150 mg P-hydroxy-coumarin 
in DMSO 
 
 
 
IF blocking solution 
 
 
10% 
0.2% 
 
 
Goat serum 
Triton-X100 
in TBS 
 
IF washing solution 
 
0.2% 
 
Triton-X100 
in TBS  
 
10x NCP (Western blot 
washing buffer) 
 
1.47 M 
0.4 M   
0.5 %  
pH 8-8.2 
NaCl 
Tris base 
Tween-20 
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10x SDS running buffer 0.25 M 
1.92 M 
1% 
Tris base 
Glycine 
SDS 
 
5x SDS loading buffer 110 mM  
20%  
3.8% 
8%  
ad libitum  
Tris/HCl pH 6.8 
Glycerol 
SDS 
β-mercaptoethanol  
BPB (Bromophenol blue) 
 
Towbin transfer buffer 25 mM 
192 mM 
20% 
 
Tris base 
Glycine 
Methanol 
Western blot blocking 
solution 
5% Non-fat Milk powder 
in 1x NCP 
 
Triton lysis buffer 150 mM 
50 mM 
1% 
1x 
NaCl 
Tris/HCl pH 7.4 
Triton-X100 
EDTA-free Complete protease 
inhibitor (Roche) 
 
SDS stacking gel (4%)  
(for 2 gels) 10 ml 
6.1 ml 
1.3 ml 
2.5 ml 
50 µl 
70 µl 
5 µl 
 
 
H2O 
30% Acrylamide (1:38) 
0.5 M Tris/HCl pH 6.8 
20% SDS 
10% APS (Ammonium Persulphate) 
TEMED 
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SDS separating gel (8%)  
(for 2 gels) 20 ml 
10.7 ml 
5.3 ml 
3.8 ml 
100 µl 
140 µl 
H2O 
30% Acrylamide (1:38) 
2 M Tris/HCl pH 8.8 
20% SDS 
10% APS (Ammonium Persulphate) 
10 µl TEMED 
   
Coupling buffer 0.1 M NaCO3 
 0.5 M 
pH8.5 
NaCl 
 
   
Blocking buffer (for Profilin2 
beats) 
0.1 M 
0.5 M 
Tris pH 8.0 
NaCl 
 
 
 
2.2 Commercial solutions 
 
2.2.1 Commercial solutions for nucleic acid analysis 
Name Manufacturer 
dNTPs 100 μM each Promega 
MgCl2 25 mM Promega 
PCR-flexi-buffer (5x) Promega 
Go-Taq Polymerase 5 u/μl Promega 
SuperScriptIII First Strand Synthesis System for RTPCR Invitrogen 
 
2.2.2 Commercial solutions for tissue culture 
Name Manufacturer 
DMEM Gibco 
DMSO Sigma 
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FCS PAA 
HEPES pH 7.2 (100x) Gibco 
L-Glutamine (100x) Gibco 
LIF Gibco 
Non essential amino-acids (100x) Gibco 
PBS Gibco 
Pen/Strep antibiotics (100x) Gibco 
Sodium pyruvate (100x) Gibco 
Trypsin (2.5%) Gibco 
Trypsin-EDTA (2.5%-0.05%) Gibco 
 
2.2.3 General tissue culture materials 
Name Manufacturer 
Cell culture flasks (75 cm3) Corning 
Cryotubes Nunc 
Pipetteman Eppendorf 
Filters Millipore 
Lab-Tek™ Chamber Slides™ Thermo Scientific 
Petri dishes (diameter 3 cm, 10 cm) VWR 
Pipettes (1 ml, 2 ml, 5 ml, 10ml, 25 ml, 50 ml) BD Falcon 
Plastic tubes (15 ml, 50 ml) Sarstedt 
Well plates (96-, 48-, 24-, 6-well) Corning 
 
2.2.4 Further material 
Name Manufacturer 
Protein transfer membrane Immobilon-P Millipore 
Bio Max XAR Film Kodak 
Microspin columns G-50 GE- Healthcare 
1.5/2 ml tubes  Roth 
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2.3 Commercial chemicals and reagents 
 
2.3.1 Liquids 
Name Manufacturer 
Acrylamide (30%) BioRad 
Bovine serum albumin (BSA) (10 mg/ml) New England Biolabs 
Bradford reagent (5x) BioRad 
Chloroform Merck 
CyQUANT® Cell Proliferation Assay Kit Life Technologies 
Dimethylsulfoxide (DMSO) Merck 
Eosin (0.05% Eosin in 96% Ethanol) Merck 
Ethanol (technical) Merck 
Ethanol, absolute Merck 
Ethidiumbromide (10 mg/ml) BioRad 
Film developer solution G153 AGFA 
Film fixer solution G354 AGFA 
Formamide Sigma 
Glacial acetic acid Merck 
Glutaraldehyde (25%) Sigma 
Glycerol Sigma 
HCl 37% Merck 
Hemalaun Merck 
Heparin Sigma 
Hydrogen peroxide (30%) Sigma 
Isopropanol Merck 
β-Mercaptoethanol Sigma 
Methanol VWR 
NBT (Nitroblue tetrazolium chloride 100mg/ml) Sigma 
Phenol Merck 
RNase Inhibitor Roche 
TaqMan® probes Life Technologies 
TEMED Sigma 
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Transcription buffer (for Digoxigenin labeling) Roche 
Triton-X100 
TRIzol® 
Roche 
Life Technologies 
Tween 20 Sigma 
 
2.3.2 Reagents 
Name Manufacturer 
Agar AppliChem 
APS Fischer Scientific 
Bromophenol blue BioRad 
BSA Merck 
Coomassie Brilliant Blue BioRad 
dpN6 Pharmacia 
DTT Sigma 
EDTA Sigma 
Glucose Merck 
Glycine Grüssing 
Luminol Sigma 
MgCl2 Sigma 
Milk powder (non-fat) Roth 
NaH2PO4 Sigma 
Na2HPO4 Sigma 
NaOH pellets Sigma 
P-hydroxy-Coumain Sigma 
Poly-L-proline (MW 40.000) Sigma 
Protease inhibitor cocktail tablets,Complete, EDTA free Roche 
Proteinase K Sigma 
SDS Merck 
Sodium chloride Merck 
Tris base Ultra  Roth 
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2.4 Technical equipment 
Description Manufacturer 
Axiovert + AxioCam Color 412-312 Zeiss 
Binocular MS 5  +  
Camera ConProgRes C10 plus +  
Light source  KL 1500 LCD  
Leica 
JENOPTIK Germany 
Leica 
Centrifuge 5415 D  Eppendorf 
Centrifuge 5417 R  Eppendorf 
Centrifuge J2-HS Beckman 
Centrifuge J2-MC Beckman 
Centrifuge tissue culture  Beckmann 
CTR 5500 + camera DFC 420 C  Leica 
Electric homogenizator Bosch 
Film developer Curix 60  AGFA 
Freezer (-80 °C)  Thermo Scientific 
Gel documentation UV Herolab 
Gel electrophoresis running chambers  BioRad/EMBL 
Glass-Teflon tissue grinders Co 
Heating blocks Grant/QBT 
Hybridization oven Bachofer 
ImageQuant LAS4000 Mini GE Healthcare 
Incubators for bacterial culture Heraeus 
Incubators for tissue culture Heraeus 
Magnetic stirrers Heidolph 
Microscopes for tissue culture Leitz 
Multi-channel pipettes Eppendorf 
Ovens Heraeus 
PTC-200 Peltier Thermal Cyclers MJ Research 
pH-meter  InoLab 
Pipette tips Molecular Bio Products 
Pipettes  Gilson 
Pipetteboy Eppendorf 
Power supply PowerPAC300 BioRad 
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Power supply PowerPAC200 BioRad 
Rocker Heidolph 
Scale Sartorius 
Scale (analytic) Kern & Sohn 
SDS PAGE apparatus Pharmacia Biotech 
Shaker New Brunswick Scientific 
Spectrophotometer Beckmann 
Thermomixer Eppendorf 
UV-Table Bachofer 
Vortex  Scientific Industries 
Water purifier Millipore 
Western blotting apparatus BioRad 
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2.5 Antibodies  
 
2.5.1 Primary antibodies 
Antigen Isotype  Dilution Manufacturer 
    
Abi1 rabbit polyclonal 1:1000 Sigma 
Abi2 mouse polyclonal 1:500 Sigma 
Actin C4 mouse monoclonal 1:2000 MP Biomedicals 
Akt rabbit polyclonal 1:1000 Cell signaling 
phoshpho Akt (Ser473) rabbit monoclonal 1.1000 Cell signaling 
Erk1/2 (p44/42 MAPK) rabbit polyclonal 1:1000 Cell signaling 
phoshpho Erk1/2 (p44/42 
MAPK) 
rabbit monoclonal 1:1000 Cell signaling 
FAK rabbit polyclonal 1:1000 Abcam 
GAPDH mouse monoclonal 1:5000 Callbiochem 
Nap1 rabbit polyclonal 1:1000 Millipore (Upstate) 
PI3-Kinase p85 (N-SH3) mouse monoclonal 1:1000 Millipore (Upstate) 
POP 5C9-E12 (Hybridoma 
supernatant) 
mouse monoclonal 1:1.5 Witke Lab 
(Massimi) 
WAVE1 mouse monoclonal 1:500 BD Bioscience 
WAVE2 rabbit polyclonal 1:500 Cell signaling 
Smad1 rabbit monoclonal 1:1000 Cell signaling 
phoshpho Smad1/5 rabbit monoclonal 1:1000 Cell signaling 
SOS1 rabbit polyclonal 1:1000 Cell signaling 
Sra1 rabbit polyclonal 1:500  Millipore (Upstate) 
α-Tubulin mouse monoclonal 1:5000 Sigma 
γ-Tubulin mouse monoclonal 1:2000 Sigma 
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2.5.2 Direct labeled Antibodies for flow cytometry 
Antigen Conjugate/Host Dilution Manufacturer 
Beta-catenin PE/mouse 1.100 eBioscience 
CD184 (CXCR4) PerCP-eFluor 710/rat 1:100  eBioscience 
Cleaved Caspase 3 Alexa Fluor 488/rabbit 1:50 Cell signaling 
Sca-1 FITC/rat 1:100 eBioscience 
SSEA1 PE/mouse 1:100 eBioscience 
 
2.5.3 Secondary Antibodies 
Secondary antibody Isotype Dilution Manufacture 
HRP goat anti-mouse polyclonal 1:5000 Merck 
HRP goat anti-rabbit polyclonal 1:5000 Merck 
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2.6 Oligonucleotides 
The Oligonucleotides in this thesis were produced by Eurofins MWG Operon. 
 
2.6.1 Oligos for mice genotyping 
Oligo Sequence (in 5’-3’ direction) 
Cre 1 (sense) (346) GCC TGC ATT ACC GGT CGA TGC AAC GA 
Cre 2 (antisense) (345) GTG GCA GAT GGC GCG GCA ACA CCA TT 
Cre 3 (antisense) (356) TCG TTG CAT CGA CCG GTA ATG CAG GC 
CyFIP 1-flox1 for (492) GTT TTA AGG AAG TCT TTG CC 
CyFIP 1-flox1 rev (493) TAA CTA AAA GAG GTA CC 
CyFIP 1-floxed rev (576) AAG ACT GAT AAG TAG CTC C 
 
 
2.7 ES cell lines  
CyFIP1+/+ 
CyFIP1+/- 
CyFIP1-/- 
Embryonic stem cell lines, 
obtained from blastocysts from 
CyFIP1 heterozygote matings.  
Generated and first 
described in this 
thesis. 
 
 
2.8 Animals 
All animals used for this thesis were bred under optimal conditions, following the 
German and EU guidelines (2010/63/UE) for welfare of laboratory animals. The mice 
were in C57/Bl6N or CD1 genetic background.  
The following mouse lines were used for the experiments: 
 
Line  Reference 
CyFIP1-/- ko Massimi (PhD Thesis), 2008 
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2.9 Molecular Weight Markers 
Name Manufacture 
SeaBlue Plus2 Pre-Stained Standard Invitrogen 
1 kb Plus DNA Ladder Invitrogen 
Broad Range marker BioRad 
Precision Plus Protein™ Dual Color BioRad 
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3.1 Molecular Biology 
 
3.1.1 Isolation of genomic DNA from mouse tail biopsies 
A 3 mm tail biopsy was cut from 17-21 days-old pups. The tail biopsy was digested in 
200 µl of Genomic DNA extraction buffer over night at 56°C. On the next day, ½ volume 
(100 µl) of saturated NaCl solution was added to the digested tails. The tubes were 
shaken vigorously for 90 seconds and centrifuged for 14 minutes at 14000 rpm. 220 µl 
of the supernatant were used to precipitate the DNA by transferring them to a new tube 
containing ~2.5 volumes (500 µl) of Ethanol. The DNA, visible by flocculation, was 
spun for 1 min at 14000 rpm and the supernatant was removed. The DNA pellet was 
dried at 37°C for a few minutes and resuspended in 200 µl of MilliQ water by shaking 
at 37°C for one hour. For PCR reaction, 1 µl of the resuspended DNA was used, while 
for southern blotting 50 µl per digestion were used. 
 
3.1.2 Isolation of genomic DNA from ES cells 
ES cells derived from blastocysts were genotyped according to the following method. 
ES cells were cultured on gelatine-coated 6 well plates for two passages to dilute out 
the feeder cells. In order to lyse ES cells, 1 ml of ES cell lysis buffer was added and 
incubated for 2 hours at 37°C. Then the lysates were recovered with a cut 1 ml tip (due 
to genomic DNA viscosity) and transferred into a 2 ml Eppendorf tube. The lysates 
were incubated over night at 56°C. On the following day, DNA was extracted by adding 
½ volume (500 µl) of a saturated NaCl solution, shaking very energetically for 90 
seconds and centrifuging for 14 min at 14000 rpm. The supernatant was transferred 
into 2.5 volumes (3.75 ml) of ethanol in a 5 ml snap cap tube. The DNA flocculated and 
after a short spin, the supernatant was removed with a pulled Pasteur-Pipette. The 
DNA pellet was dried at 37°C for a few minutes and resuspended in 500 µl of MilliQ 
water and shaken at 37°C for one hour to obtain complete dissolution. 1 µl of a 1/10 
dilution was used for the PCR reaction. 
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3.1.3 Isolation of genomic DNA from amnion or yolk sac 
Genomic DNA was extracted from the amnion or yolk sac by Proteinase K digestion 
(0.5 mg/ml) of the tissue in 20 µl of MilliQ water overnight at 56°C. The following day 
Proteinase K was inactivated by increasing the temperature to 98°C for 10 min. After 
cooling and a short centrifugation, 1 µl of the supernatant was used for the PCR 
reaction. 
 
3.1.4 Phenol-chloroform extraction of DNA 
Phenol-Chloroform extraction is a way to remove proteins from nucleic acid samples. 
It was employed on some genomic DNA samples if the PCR reaction was not clear to 
increase the purity of the template DNA. 
Phenol/Tris-(pH 7.4)-Chloroform (1:1) was added with a ratio of 1:1 to the DNA 
solution, and thoroughly shaken for 30 sec. The emulsion was centrifuged for 10 min 
at 14.000 rpm to obtain a separation of the phases. The aqueous, DNA-containing, 
phase on top was carefully transferred into a new Eppendorf tube. The DNA was 
precipitated adding 2.5 volumes of Ethanol and centrifuging for 10 min. After removal 
of the supernatant, the pellet was dried and dissolved in H2O. 
 
3.1.5 Genotyping of mice, ES cells, and embryos by PCR 
The polymerase chain reaction (PCR) is a widely used technique in molecular biology. 
It is an enzymatic way to amplify a DNA template in replicative cycles using short 
oligonucleotide primers and free deoxynucleotides. Specific sense and antisense 
primers flanking the desired target sequence were used. There are three main steps 
in each PCR cycle: denaturation, annealing and extension. The reaction mixture is first 
heated to a temperature between 95-98°C that ensures DNA denaturation. The mixture 
is then cooled to a temperature (generally, between 55-65°C) that permits annealing 
of the primers to the complementary sequences in the single-stranded DNA. The short, 
typically 18 to 24 bases, oligonucleotide primers should have a defined GC content 
(40-60%) that determines the annealing temperature. The extension step typically 
occurs at 72°C. In the presence of the four dNTPs the Taq Polymerase synthesizes 
new DNA strands starting at the 3’-end of the annealed primers. These steps are 
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repeated for 25-35 cycles. A final extension step at 72°C for 3-10 min is usually 
performed to ensure that the new DNA fragments are complete. 
The amplified DNA products can be visualized by gel electrophoresis using agarose 
gels after staining with ethidium bromide or other fluorescent intercalating agents. 
 
3.1.5.1 Genotyping of CyFIP1 ko mice 
Oligo sequences are found in the Materials (2.6.1). 
PCR Mix for 20 μl of Total Reaction Volume: 
11.2 µl   H2O 
     4.0 µl 5 × Flexi Buffer 
  1.2 µl MgCl2 (25mM) 
  0.4 µl dNTPs (10mM) 
     1.0 µl Oligos 492/493 (20 mM) 
     1.0 µl Oligos 492/576 (20 mM) 
  0.2 µl Taq-Polymerase 
     1.0 µl Genomic DNA 
 
Programme (CKO-Pfn2) 
98°C for 2 min  
96°C for 30 sec 
55°C for 1 min 15 sec                 35 cycles   
72°C for 30 sec 
72°C for 5 min 
15°C forever 
 
Expected PCR products: 
wild type band: 270 bp 
deletion band: 410 bp 
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3.1.5.2 Genotyping of Cre-deleter mice 
PCR Mix for 20 μl of Total Reaction Volume: 
11.2 µl   H2O 
     4.0 µl 5x Flexi Buffer 
  1.2 µl MgCl2 (25mM) 
  0.4 µl dNTPs (10mM) 
     0.5 µl Oligos 346/345 (20 mM) 
     0.5 µl Oligos 149/150 (20 mM) 
  0.2 µl Taq-Polymerase 
     1.0 µl Genomic DNA 
 
Programme (Cre-P) 
98°C for 2 min  
96°C for 30 sec 
58°C for 30 sec                 30 cycles   
72°C for 40 sec 
72°C for 5 min 
15°C forever 
 
Expected PCR products: 
wild type (gelsolin) band: 264 bp 
Cre band: 600 bp 
 
3.1.6 Gel electrophoresis 
The DNA products amplified by PCR can be visualized by gel electrophoresis. Gels 
were prepared, depending on the size of DNA fragments, by melting 0.8-2% (w/v) 
agarose in 1× TAE buffer and adding 7 µl of ethidium bromide per 100 ml of gel. In the 
electrophoresis chamber the gel was covered with 1× TAE buffer. DNA loading buffer 
was added to the DNA (PCR products have the loading buffer included in the PCR 
mix) and samples were pipetted in the gel slots. The gel was run at constant voltage 
(20-90V) for 30-90 min. Finally, gels were documented using a gel documentation 
system with UV illumination (BioRad). 
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In order to measure the RNA concentration and determine the purity of the RNA, 1 μl 
of this solution was measured with the NanoVue (GE Healthcare) spectrophotometer. 
 
 
3.2 Cell Biology 
 
3.2.1 ES cell culture 
Cell culture was performed under sterile conditions in a sterile laminar flow hood with 
sterile media, glass and plastics. Cells were cultured in a humidified incubator at 37°C 
in 5% CO2 atmosphere. 
ES cells were grown in tissue culture plates or flasks coated with gelatine, on a layer 
of mouse embryonic fibroblasts (MEFs) inactivated by -irradiation in ES Cell Medium, 
which was changed daily. ES cells were passaged every 3-4 days. For passaging ES 
cells, medium was removed, and then cells were washed twice with PBS and incubated 
in Trypsin-EDTA for 5 min at 37°C. In order to inactivate trypsin, at least 1 volume of 
ES Cell Medium was then added and the cells were resuspended to a single-cell 
suspension, transferred to a 15 ml tube and centrifuged at 760 rpm for 5 min. The pellet 
was resuspended in an appropriate volume of ES Cell Medium and cells were plated 
on new gelatine coated plates with freshly plated MEFs.  
 
3.2.2 Freezing and thawing of ES cells 
ES Cells can be stored for long periods of time in liquid N2. 
In order to freeze ES cells, they were treated with trypsin and centrifuged as previously 
described (3.2.1 Cell Culture). Afterwards the cell pellet was resuspended in ice-cold 
ES cell freezing medium and transferred into cryo-vials. Vials were frozen overnight at 
-80°C. The following day, the vials were transferred into liquid nitrogen. 
ES cells were thawed in a 37°C water bath. Immediately after thawing, cells were 
complemented with ES Cell Medium, transferred in a tube, and centrifuged (760 rpm, 
5 min).  
The pellet was resuspended in ES Cell Medium and plated onto a 10 cm dish coated 
with gelatine, on a monolayer of freshly plated mitotically inactivated MEFs. 
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3.2.3 Generation of mouse Embryonic Stem (ES) cells 
 
3.2.3.1 Blastocysts preparation from mice 
Time-mated females were sacrificed at embryonic day 3.5. The uteri were dissected 
and transferred to a petri dish containing ES Cell Medium. With scissors and forceps 
the uteri were cleaned from fat. A clean uterus was transferred to a 35 mm dish and 
the blastocysts were flushed out of the uterine horn using a 3 ml syringe with a 27G 
needle, using ES Cell Medium. The whole process was performed on an inverted 
microscope. Blastocysts were collected with a capillary tube and pipette and 
transferred singularly into the wells of a 48-well plate containing a layer of mitotically 
inactivated MEFs. 
 
3.2.3.2 ES cell derivation 
Blastocysts were incubated at 37°C with 5% CO2 for approximately two days in 48-well 
plates. During this period it is important to avoid any interference. After attachment to 
the feeder layer, the blastocysts hatch and the ES Cell Medium can be changed. The 
inner cell mass (ICM) then expanded and 5 or 6 days after plating of the blastocyst a 
defined ES cell-like population could be seen in the expanded ICM. The cells were 
then trypsinized for the first time and plated again on a new 48-well plate on fresh MEF 
feeder layer. The typical appearance of mouse ES cell clones was normally seen 4-5 
days after the first trypsinization. The following days the ES cells grew and were finally 
trypsinized a second time and plated on a 6-well plate and finally expanded to 75 cm2 
flasks. ES cells can then be frozen in ES cell freezing medium. Normally eight 1 ml 
aliquots were frozen from a 75 cm2 flask of each established mouse ES cell line.  
 
3.2.3.3 ES cell differentiation 
Mouse embryonic stem cells are derived from the ‘inner cell mass’ of blastocysts and 
have pluripotent properties. Embryonic stem cells of mouse can differentiate into 
different embryonic tissues depending on culture conditions. 
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3.2.3.3.1 Spontaneous differentiation into embryoid bodies 
ES cells were trypsinized from a cell culture dish and pipetted to obtain a single-cell 
suspension. The cells were then transferred onto a Petri dish in ES cell differentiation 
medium to induce differentiation. After a few days in culture they formed cell 
aggregates of different sizes. The cells could not attach to the surface of the Petri dish 
and grew in suspension. The medium was carefully changed every second day. 
Culture was stopped after 7 days. The derived embryoid bodies varied greatly in size. 
 
3.2.3.3.2 Hanging-drop method for embryoid bodies 
To control the size of the cell aggregates more precisely, the hanging drop method 
was used. After trypsinization, ES cells were resuspended in ES cell differentiation 
medium and counted with a haemocytometer. Fifty drops of 20 μl, containing 
approximately 1500 cells, were deposited on the interior of a cover of a 10 cm Petri 
dish and the cover was set over the bottom part containing PBS. After two days in 
culture at 37°C each drop contained a small aggregate of cells, which was transferred 
to a Petri dish and cultured for additional 4 days. During this period, medium was 
changed carefully every second day.  
 
 
3.3 Flow cytometry analysis 
Flow cytometry is a widely used method for characterizing and separating individual 
cells. With Flow cytometry it is possible to measure certain physical and chemical 
characteristics of cells or particles as they pass in a fluid stream by a beam of laser 
light. Cells or EBs in this work were grown like described previously and analyzed by 
flow cytometry. 
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3.3.1 Preparation of ES cells for flow cytometry analysis 
ES cells were trypsinized from a cell culture dish and pipetted in ES cell Medium to 
obtain a single-cell suspension. After centrifugation the ES cells were resuspended in 
MACS Buffer and stained as followed in 3.3.3 or 3.3.4. 
 
3.3.2 Preparation of EBs for flow cytometry analysis 
The EBs, which were grown in suspension in Petri dishes, were transferred carefully 
into 50 ml falcon tubes. For 10 min the EBs were allowed to settle down to the bottom 
of the falcon tube. The supernatant was removed and EBs were washed two times 
with PBS. A gentle spin for 5 minutes at 500 rpm was done to collect the EBs at the 
bottom of the tube when in PBS. Supernatant was discarded. An appropriate volume 
of MACS buffer (approximately 15-25 ml per falcon depending on the amount of EBs) 
was added and incubated at RT for about 15 min with pipetting in between until a single 
cell suspension was visible under the microscope. Around 106 cells were transferred 
to an eppendorf tube for each antibody staining and flow cytometry assay. The cells 
were kept on ice at 4°C. 
 
3.3.3 Extracellular antibody staining for flow cytometry 
All steps were performed at 4°C.The cells in Eppendorf tubes were spun down for 5 
min at 1000 rpm, the supernatant discarded and the pellet resuspended in 100 µl of 
MACS buffer. 1 µl of the appropriate fluorescently-labelled primary antibody was added 
and incubated at 4°C in the dark for 45 min. After 45 min, 500 µl of MACS buffer were 
added to dilute the antibody and spun down at 1000 rpm for 5 min. The supernatant 
was discarded and the cells were washed once in 500 µl of MACS buffer and spun 
down again. After the supernatant was removed the cells were resuspended in 200 µl 
of MACS buffer and analyzed by flow cytometry (BD Accuri C6). 
 
3. Methods 
53 
 
3.3.4 Intracellular antibody staining for flow cytometry 
All steps were performed at 4°C. The cells collected in Eppendorf tubes were spun 
down for 5 min at 1000 rpm, the supernatant discarded and, in order to fix the cells, 
resuspended in 300 µl 2% PFA and incubated for 10 min at 4°C. Then 500 µl of MACS 
buffer were added to dilute the PFA. After fixation centrifugation must be performed at 
3000 rpm for 5 min to minimize cell loss. Supernatant was discarded and cells washed 
once with 500 µl of MACS buffer and treated as previously described. The cells were 
resuspended in in 300 µl of MACS Buffer with 0,1% TritonX and 1% fish gelatine and 
incubated for 45 min to permeabilize and block the cells. Afterwards cells were spun 
down and resuspend in 100 µl of MACS buffer. 1 µl of the appropriate fluorescently-
labelled primary antibody was added and the cells were incubated at 4°C for 45 min in 
the dark. After 45 min, 500 µl of MACS buffer were added to dilute the antibody and 
cells were spun down at 1000 rpm for 5 min. The supernatant was discarded and the 
cells were washed once in 500 µl of MACS buffer and spun down again. After the 
supernatant was removed the cells were resuspended in 200 µl of MACS buffer and 
analyzed by flow cytometry (BD Accuri C6). 
 
 
3.4 CyQuant assay 
The CyQuant assay (Life Technologies) uses DNA quantification as a measure to 
determine the number of cells, so it can be used for proliferation, differentiation and 
adhesion assays. The cells were seeded in triplicates in 96-well-plates at a defined 
density with 200 µl of medium. One plate was prepared for each time point. For the 
proliferation and differentiation assays cells were cultured for 1, 2, 3, 4 and 5 days, 
with medium changes every second day. For the adhesion assay cells were cultured 
for 1, 2, 3 and 4 hours. The time point zero was done by spinning cells down at the 
moment of plating for 5 min at 1000 rpm to attach them mechanically to the plate. After 
the respective incubation period, the medium was removed from the plates. The wells 
were carefully washed twice with PBS. The plates were then frozen at -80°C. The 
freezing step is critical for cell lysis. The plates can be stored at -80°C for up to 4 
weeks. For the assay, a working solution was prepared by adding 50 µl of CyQuant 
GR stock solution (Component A) to a mixture of 1 ml cell lysis buffer stock solution 
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(Component B) and 19 ml of nuclease-free water in a 50 ml tube protected from light. 
After the 96-well-plates were thawed at room temperature, 200 µl of the working 
solution were added to each well and the plates were incubated for 5 minutes. The 
fluorescence was determined by a microplate reader (Victor, Perkin Elmer) at an 
excitation wavelength of 480 nm and an emission wavelength of 520 nm. 
 
 
3.5 Microarrays 
The RNA expression levels of large numbers of genes can be analyzed by Microarrays. 
Illumina BeadChip arrays were used. The BeadChip arrays are constructed by 
introducing oligonucleotides bearing 3-micron beads to microwells etched into the 
surface of a slide-sized, silicon substrate. During the manufacturing process, beads 
self-assembly into the microwells of the BeadChip arrays. Each bead contains 
hundreds of thousands of copies of covalently-attached, oligonucleotide probes and is 
represented with an average of 30-fold redundancy (Illumina).  Cells were grown as 
described previously and trypsinized from a 10 cm cell culture dish. One wash in PBS 
was performed. Cells were lysed in 1ml of TRIzol® with pipetting up and down several 
times and immediately frozen at -20°C until processing. 
The Microarray and data analysis was done in the Microarray facility of Joachim 
Schulze, LIMES Institute. 
 
  
3. Methods 
55 
 
3.6 Biochemistry 
 
3.6.1 Protein Lysates 
 
3.3.6.1 Preparation of protein lysates from mouse tissues  
Mouse organs were dissected on ice, shock-frozen in liquid nitrogen and stored at-
80°C. Fresh organs were also used for protein lysates. The organ was placed in Triton 
Lysis buffer in a Glass-Teflon douncer and homogenized at constant speed (250-500 
rpm) on ice until the tissue was completely dissociated. 
The homogenized tissue was centrifuged for 15 min at 14000 rpm at 4°C. The 
supernatant was transferred to a fresh tube and the protein concentration was 
determined using the Bradford assay. Protein lysates were shock-frozen and stored at 
-80°C. Diluted lysates in 1× SDS loading buffer were denatured by heating at 95°C for 
10 min and stored at -20°C. 
 
3.3.6.2 Preparation of protein lysate from cultured cells 
Adherent growing cells were trypsinized (see protocol), culture medium was added and 
the cell suspension was collected in a 15 ml Falcon tube. The cells were spun down 
for 5 minutes at 7600 rpm and washed twice with 5 ml of ice cold PBS. 
 
3.3.1.6.1 Cytoplasmic and nuclear cell lysates 
To prepare cytoplasmic and nuclear extracts, the cells were lysed in Triton lysis buffer 
(see 3.3.1.1) for 10 min on ice, after resuspending the cell pellet by pipetting up and 
down with a blue tip, and transferred into a 1.5 ml tube. Normally, for a 10 cm dish 
growing to confluence, 300 µl of Triton lysis buffer were used. The lysate was then 
spun down for 10 min at 14000 rpm at 4°C. The supernatant, which contained the 
cytoplasmic fraction, was transferred into a new tube. SDS loading buffer was added 
to a final concentration of 1x. Protein concentration was determined using the Bradford 
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assay. The pellet, which contained the nuclei, was washed once in Triton lysis buffer 
and lysed in 20-50 µl 2x SDS loading buffer. The lysates were denatured and genomic 
DNA sheared with 3-4 cycles of 2 minutes at 99°C and 15-30 seconds vortexing, 
cooled on ice and stored at -20°C. Protein concentration was determined using the 
Bradford assay. 
 
3.3.1.6.2 Total lysates 
For total protein extraction, cells were lysed in 2x SDS loading buffer. In order to shear 
genomic DNA and denature the proteins, the lysates were boiled for 2 min at 99°C and 
vortexed for 15-30 seconds for 3-4 times. Protein concentration was determined with 
the Bradford essay. Lysates were stored at -20°C. 
 
3.6.2 Western blotting 
 
3.6.2.1 Discontinuous SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE (Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis (PAGE) 
(Laemmli 1970)) is a method to separate proteins according to their molecular weight. 
Since proteins with similar molecular weights may migrate differently due to their 
difference in structure or net charge, SDS, an anionic detergent, and β-
Mercaptoethanol, a reducing agent, are used to denature proteins to their primary 
(linearized) structure and coat them with a uniform negative charge. 
Acrylamide gels are composed of two layers: an upper layer about 2 cm long and with 
a fixed acrylamide concentration of 4%, called “stacking gel”, needed to compact 
proteins in one line; a lower layer about 5 cm long, called “resolving gel”, needed to 
separate the proteins: the size of the proteins of interest determine the acrylamide 
percentage to be used for this gel. The components of the WAVE complex (except for 
HSPC300) were analyzed using 8% acrylamide gels. Samples in 1X SDS loading 
buffer were loaded on the gel. To identify the size of the proteins, 7 μl of See Blue 
Plus2 Pre-Stained Molecular Weight Standard (Invitrogen) or 6 μl of Broad Range 
Unstained MW Standard (BioRad) were also loaded. Electrophoretic separation was 
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obtained in 1x running buffer at 80 V through the stacking gel and at 130 V through the 
resolving gel. The electrophoresis was stopped when the 50 kDa marker band reached 
the bottom of the gel. 
 
3.6.2.2 Blotting (wet blot) 
The high molecular weight proteins of the WAVE complex were transferred to a 
membrane with wet blots. Following SDS-PAGE, the gel was equilibrated in transfer 
buffer. 3MM Whatman sheets and a PVDF membrane were cut to the size of the gel 
and soaked in transfer buffer. The PVDF membrane was first activated by immersion 
for a few seconds in methanol. The gel and the membrane were packed between the 
soaked 3MM paper pieces and two sponge pads in perforated plastic plates as follows: 
Anode (+) 
Sponge pad 
2 Whatman sheets 
PVDF membrane 
Polyacrylamide gel 
2 Whatman sheets 
Sponge pad 
Cathode (-) 
 
The transfer was performed in a blotting tank for 90 min at 110 V at 4°C or overnight 
at 20 V at room temperature. 
 
3.6.2.3 Protein detection 
After transfer of the proteins to the PVDF membrane, the membrane was blocked for 
30 min in blocking solution. The primary antibody was diluted in blocking solution to an 
appropriate concentration and the blot was incubated either for 2 h at room 
temperature or overnight at 4°C. The membrane was washed three times for 10 min in 
1x NCP. Incubation of the blot with the secondary antibody conjugated to horseradish 
peroxidase (HRP) was carried out for 1 h at room temperature in blocking solution with 
a dilution of 1:5000. The membrane was again washed three times for 10 min in NCP 
1x. The protein of interest was detected by enhanced chemical luminescence (ECL) 
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utilizing the reaction of Luminol and H2O2, which is catalyzed by the HRP. For this 
purpose, the membrane was incubated with the ECL reagent for 1 min and the 
chemiluminescent signal was acquired with a LAS4000 Mini (GE Healthcare) imager. 
 
3.6.3 Coomassie staining  
Coomassie reagent was used to stain proteins on an acrylamide gel in order to 
estimate the protein concentration and the quality of the lysates.  
Gels were first fixed by incubation in 40% Methanol and 10% Acetic acid in Milli-Q 
water for 30 minutes (this step was only necessary for gels that were not previously 
blotted, in fact the transfer buffer contains methanol, therefore blotted gels are already 
fixed). Then the gels were stained in Coomassie solution for 30 min at room temp. 
Finally the gels were washed twice for 15 minutes in 40% Methanol and 10% Acetic 
acid in H2O and twice for 30 minutes in 20% Methanol and 10% Acetic acid in H2O. 
Coomassie stained gels were stored in distilled water. 
 
3.6.4 Coupling of Profilin2 to sepharose beads 
Profilin2 beads were made by dissolving 50 mg of Profilin2 in 12 ml of coupling buffer 
(0.1 M NaCO3, 0.5 M NaCl, pH8.5). 1,5 g of dry CNBr-activated sepharose 4B were 
weighted (1 g of lyophilized powder gives about 3.5 ml final volume of medium) and 
suspended in 1 mM HCl. The medium was swelling immediately and then washed for 
15 minutes with 1 mM HCl on a sintered glass filter (porosity G3). Then the beads were 
washed briefly with cold water and coupling buffer. The beads were added immediately 
to the dissolved Profilin2 and incubated on a test tube rotator overnight at 4°C. 
The next day, the beads were washed three times with 40 ml of coupling buffer and 
blocked with 0.1 M Tris pH 8.0, 0.5 M NaCl for 2 hours at RT. Then the resin was 
washed 4 times (alternating with 0.1 M sodium acetate pH 4.0, 0.5 M NaCl and 0.1 
M Tris pH 8.0, 0.5 M NaCl). The beads were stored in 20 mM Tris pH 8.0, 5 mM EDTA, 
0.1 M NaCl, 0.1% NaN3 at 4°C. 
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3.6.5 Profilin2-beads pull-down 
The pull-down assay was performed in a cold room at 4°C. First columns were washes 
with 500 μl of lysis buffer. Then Columns were filled with 100 μl of lysis buffer. 
Afterwards a solution containing 100 μl of Profilin2-beads and 100 μl of water was 
added on top of the lysis buffer. The beads were left to settle and then washed twice 
with 500 μl of lysis buffer before the protein lysates with a total protein amount of 250 
mg were added. The flow-though was collected and added two more times to the 
column. The last flow-through, (unbound fraction) was transferred into a new tube and 
stored in 1x SDS loading buffer. To remove unbound proteins from the columns, they 
were washed 5 times with 800 μl of lysis buffer. After washing, 150 μl of 2x SDS-
loading buffer were added to each column and the beads were thoroughly mixed by 
pipetting up and down. The solution containing the beads (bound fraction) was 
transferred into a new tube and stored. All fractions were boiled at 99°C and vortexed 
in between (the bound fraction had to be vortexed carefully). The unbound and the 
wash fraction were shortly spun down and stored at -20°C. The bound fraction was 
spun down at 1000 rpm for 5 min to separate the beads from the supernatant. The 
supernatant was transferred into a new tube and both were stored at -20°C. 
 
 
3.7 Histology 
3.7.1 Paraffin embedding of ovaries for morphological studies 
For paraffin embedding, the ovaries were fixated in an eppendorf tube with 1 ml of 2% 
PFA in PBS overnight at 4°C with shaking. The next day the tissues were washed three 
times for 30 minutes in PBS at 4°C and then again in fresh PBS overnight. Dehydration 
was performed at 4°C on a shaker in increasing alcohol concentrations. After two hours 
in 50% ethanol/H2O the tissues were placed in 75% ethanol. The ethanol was replaced 
after two hours and the ovaries were incubated at least overnight at 4°C. The 
dehydration process was completed at room temperature with two 30 minutes 
incubations in 96% ethanol and two 30 minutes incubations in absolute ethanol. After 
dehydration the ovaries were transferred in glass vials and cleared incubating for three 
times 30 minutes in xylene. Then xylene was replaced with paraffin at 60°C. The 
ovaries were incubated in paraffin in a heating block at 60°C twice for at least 45 
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minutes, then in fresh paraffin overnight and the next day again 45 minutes in new 
paraffin. At last the each ovary was oriented in a small embedding mould, covered with 
an appropriate amount of paraffin and allowed to solidify at room temperature. The 
hardened paraffin block was then taken out of the mould, trimmed with a razor blade 
and mounted on a tray with melted paraffin ready to be cut with the microtome. 
 
 
3.7.2 Hemalaun and Eosin (H&E) staining 
The H&E staining was performed on paraffin sections of the mouse ovary. First the 
sections were deparaffinated and rehydrated, all steps taking place under the fume 
hood. The slides were placed in a glass shuttle and dipped three times for 10 minutes 
in a glass tray with xylene and then transferred to trays with decreasing alcohol 
concentrations for four minutes each: absolute ethanol, 96%, 75% and 50% ethanol. 
Then the slides were submerged in distilled water for 10 minutes before the staining. 
First the sections were stained with Meyers Hemalaun for 15 seconds and 
subsequently blued for 30 seconds to one minute under flowing tap water (nuclear 
staining). The counterstaining was realized with eosin/ethanol for two minutes. Then 
the slides were rinsed under flowing tap water until no more color came off and dipped 
for 30 seconds in 96% ethanol, then two minutes in absolute ethanol and finally for 2 
minutes in xylene. The sections were mounted with Entellan and left to dry overnight 
under the fume hood and the imaged under the microscope. 
 
 
.  
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4.1 Analysis of the infertility phenotype in CyFIP1+/- females  
 
4.1.1 CyFIP1+/- females show infertility 
Previous observations showed that CyFIP1 heterozygous (+/-) females, starting at the 
age of about three months, were less fertile than wild type females of the same age. 
Only 19% of CyFIP1+/- plugged females were pregnant in contrast to 72% of wild type 
females (figure 14, (Stoecker 2010)).  
 
 
Figure 14: Comparison between CyFIP1+/- and wild type pregnancies of plugged females. Percentage 
representation of pregnant females in CyFIP1+/- matings (n=31) and wild type matings (n=25). Females were 
older than 3 months and in a C57BL/6N genetic background (Stoecker 2010). 
 
In order to identify the role that CyFIP1 plays in ovaries and the reason for premature 
infertility in CyFIP1 heterozygous female mice, their ovaries were analyzed in 
comparison to wild type ovaries from age-matched littermates. 
 
4.1.2 WAVE complex stability in ovaries 
Previous experiments showed that the entire WAVE regulatory complex was down- 
regulated in the CyFIP1 knockout embryos (Stoecker 2010). Therefore the first 
question was if and how the components of the WAVE complex would also be affected 
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in the ovaries of CyFIP1+/- females. CyFIP1, as expected, was found reduced in 
protein extracts from heterozygous ovaries (figure 15). Surprisingly also the other three 
WAVE complex components analyzed showed a reduction in their levels (figure 15). 
Although Nap1 appeared expressed at much lower levels than in brain it was further 
reduced in extracts from heterozygous ovaries. Abi1 showed a double band running 
slightly higher compared to the two bands in the brain control, but it is well known that 
Abi1 has different splice isoforms in different tissues (at least 15 isoforms have been 
characterized in total). WAVE2 appeared very weak in the brain control, which is 
normal since WAVE1 and 3 are the predominant isoforms in the brain, and it was very 
clearly reduced in heterozygous ovaries. Overall more than 50% of the WAVE complex 
was lost in CyFIP1 heterozygous ovaries (figure 15). 
 
 
Figure 15: Western blot analysis of the WAVE complex in CyFIP1 heterozygous ovaries. Two wild type 
lysates and four CyFIP1 heterozygous lysates of ovaries from 3 months old females were loaded as indicated. 
A brain lysate was used as positive control. Examined proteins: CyFIP1, Nap1, Abi1, and WAVE2. Reference 
protein for loading control: GAPDH. A reduction of CyFIP1, Nap1, Abi1 and WAVE2 is evident in the 
heterozygous ovaries. 
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4.1.3 Morphological analysis of the ovaries 
In order to understand what effect the reduction of WAVE complex availability was 
having on the ovaries, firstly ovaries from 3 weeks old CyFIP1+/- and wt females were 
analyzed to see if any morphological differences could be detected at this early stage, 
considering that female mice become fertile at about 5-6 weeks of age. Therefore, the 
ovaries were taken and analyzed before the mice became fertile and had an estrous 
cycle. Ovaries were embedded in paraffin, sectioned and stained with H&E. The gross 
morphology of wt and CyFIP1+/- ovary sections after H&E staining resulted very similar 
(figure 16).  
 
 
Figure 16: Sections of wild type and CyFIP1+/- ovaries from 22 days old mice. (A) Sample section from a 
wt ovary stained with H&E shows the presence of follicles at different stages of development. (B) Sample section 
from a CyFIP1+/- ovary similarly stained shows no difference from the wt at this time point. 
 
Then ovaries from mature 3 month old mice were embedded in paraffin, sectioned and 
stained with H&E. Prior to embedding, the ovaries were imaged at the dissection 
microscope and measured. Measuring the ovary surface area showed in average no 
significant difference between wild type and CyFIP1 heterozygous ovaries (see 
appendix figure 38). 
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4.1.4 Follicle development analysis 
At early time point before fertility no major differences in morphology could be detected 
in follicles. Ovaries from sexually mature mice were analyzed more in depth. Follicle 
development is essential for fertility, therefore a detailed analysis of the number of 
follicles at each developmental stage was performed in CyFIP1+/- ovaries from 
females of 2-3 months of age. Follicles are classified according to their developmental 
stage as previously explained (Introduction 1.8.1) and for this study a classification in 
five types was chosen (figure 17).  
 
 
Figure 17: Classification of follicle types in H&E stained paraffin sections of the ovary. Type 1: primordial 
and primary follicles. Type 2: secondary follicles. Type 3: early antral follicles. Type 4: antral and pre-ovulatory 
follicles. Type 5: follicle-like structures without oocyte. 
 
Groups of three consecutive wt and CyFIP1+/- 10 m thick ovary sections at intervals 
of 100 m were stained by H&E in order to properly identify all the follicles in the ovary 
and minimize double counting. 
The numbers of Type 1 to Type 4 follicles showed no significant difference between 
CyFIP1+/- ovaries and wt ovaries. Nevertheless, the quantity of Type 1 and Type 3 
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follicles tended to be slightly lower in CyFIP1+/- ovaries, while a reverse trend was 
observed in follicles of Type 2 and Type 4. The comparison of Type 5 follicles, however, 
showed a significant difference (p=0.018) with 64 follicles in the ovaries of 
heterozygous animals compared to only 36 in the wild type littermates (figure 18). 
 
 
Figure 18: Comparison of the number of follicles of the 5 types present in the ovaries of wild type and 
CyFIP1 heterozygous females. Bars represent number of follicles classified according to their developmental 
stage. Type 1: primordial and primary follicles. Type 2: secondary follicles. Type 3: early antral follicles. Type 4: 
antral and pre-ovulatory follicles. Type 5: follicle-like structures without oocyte. The difference in the number of 
Type 5 follicles between wt and het is significant (wt n=3 and CyFIP1+/- n=4, t-test * 0.05>p>0.01). 
 
 
4.1.5 Follicle dimensional analysis 
Another possible indicator of follicular developmental defects is the size of the different 
types of follicles. The diameter of every Type 1 to Type 4 follicle counted in the previous 
section was measured, in order to compare their size distribution within each type in 
wild type and CyFIP1 heterozygous mice. Type 5 follicles were too heterogeneous in 
size to be included in this analysis. No significant differences in size were found in 
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Type 1-3 follicles (data not shown). Type 4 follicles, on the contrary, showed a 
significant difference in size distribution between wt and CyFIP1+/- animals. CyFIP1+/- 
type 4 follicles appeared to be in the majority of cases smaller than the controls (figure 
19, where the distribution is represented as a survival graph respect to follicle 
diameter). It appeared clear that only 1 heterozygous female showed higher 
percentage of larger Type 4 follicles while only 1 wt had significantly less of the larger 
Type 4 follicles. Note that females were not synchronized in hormone cycle, therefore 
a certain variability is expected. 
In summary, ovaries of CYFIP1+/- females showed a reduction of the WAVE complex 
components: CyFIP1, Nap1, Abi1, and WAVE2. Accordingly, follicle number and size 
was affected in CyFIP1+/- females: the follicle analysis showed higher number of Type 
4 follicles and significantly higher numbers of Type 5 follicles in CyFIP1+/- ovaries. 
Also, the size of Type 4 follicles was reduced in CyFIP1+/- mice. 
 
 
Figure 19: Survival analysis of the size of antral and preovulatory (Type 4) follicles of CyFIP1+/- females.  
Individual survival curves of follicle size (average diameter) showed that in the majority of CyFIP1+/- females 
follicles were significantly smaller than in wt. Statistical analysis using Logrank (Mantel-Cox) test gave p=0.0217. 
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4.2 Analysis of the CyFIP1 knockout mouse 
 
4.2.1 Genetic background and mutation inheritance 
As previously shown by Massimi, CyFIP1 is ubiquitously expressed in most adult 
tissues and during all embryonic stages as early as the embryonic stem cell stage. 
Since it was known that the knockout mouse was early embryonic lethal, to minimize 
the genetic variability and better define the window of lethality, heterozygous CyFIP1 
knockout mice originally in a C57BL/6J background were crossed into C57BL/6N 
background. CyFIP1-/- embryos were then obtained by intercrossing CyFIP1+/- 
animals. These knockout mice appeared to die much earlier than described in previous 
work from Massimi (see Introduction 1.7.2), around embryonic day 6.5 (E6.5). 
Moreover, in this background, the phenotype of CyFIP1 heterozygous females 
described above (section 4.1) became evident: a highly reduced fertility. In an attempt 
to overcome this problem the CyFIP1 knock out mouse was backcrossed into a CD1 
background. The CD1 mice are characterized by higher fertility, better maternal 
behavior and bigger litter size. After five generations of backcrossing with CD1 mice, 
timed matings between CyFIP1 heterozygous mice were resumed. Embryos were 
collected at E6.5, E7.5 and E8.5, imaged and genotyped by PCR. All three possible 
genotypes were found at these stages in CD1 genetic background with an overall 
correct Mendelian distribution (figure 20). Nevertheless the morphological analysis of 
the mutant embryos at the same stages as wild types indicated severe developmental 
differences. 
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Figure 20: Distribution of the genotypes obtained from heterozygous matings in CD1 background at 
different early embryonic stages. Percentage representation of the genotypes of embryos dissected at E6.5, 
E7.5 and E8.5 showed a normal Mendelian ratio with slight preference for heterozygosity. E6.5: 1 litter, 12 pups; 
E7.5: 4 litters, 49 pups; E8.5: 3 litters, 27 pups. 
 
 
4.2.2 Morphological analysis of Cyfip1 null mutant embryos 
A morphological analysis of the embryos was performed to better define the time point 
of embryonic lethality. At time point E6.5, the differences between the mutant and the 
control were already quite obvious: CyFIP1-/- embryos appeared delayed in 
development. E6.5 wt embryos had reached Ts10 (see Introduction 1.11.3 for the 
definition of Theiler stages), while CyFIP1-/- embryos were still around Ts7 (figure 
21A,B). CyFIP1-/- embryos at E7.5 were much smaller than controls and don´t develop 
properly (figure 21C,D). Finally at E8.5 CyFIP1-/- embryos had an overall degenerated 
aspect and the tissues appeared degraded. The mutants showed no morphology 
similarities to the controls anymore (figure 21E,F). 
In conclusion CyFIP1-/- embryos showed severe developmental problems starting at 
the time point where gastrulation and germ layer formation take place.  
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Figure 21: Morphology of control sample and CyFIP1-/- embryos at developmental day E6.5, E7.5 and 
E8.5. Control sample embryos (A,C,E), and Cyfip1-/- sample embryos (B,D,F). The genotype was determined 
by PCR on the whole embryo after imaging. 
 
 
4.3 Characterization of CyFIP1 ko mouse-derived ES cells 
In order to study early embryogenesis events, an alternative approach to embryonic 
analysis is the establishment of ES cell lines where defects in adhesion, proliferation, 
and differentiation can be analyzed. This approach was, therefore, chosen to elucidate 
the relevance of CyFIP1 in these processes and infer its function(s) in early embryonic 
development, since in vitro assays are a reproducible, easier to handle and validated 
system, and allow a substantial reduction of the use of experimental animals. For this 
reason ES cells were prepared from blastocysts (E3.5) collected after mating 
CyFIP1+/- mice of the C57Bl/6N genetic background. Briefly, blastocysts were 
singularly deposited on a feeder layer (mitotically arrested fibroblasts) and hatched for 
5-6 days, then trypsinized and re-plated for 4-5 more days, when they were trypsinized 
a second time and finally plated as an established line. ES cells were kept on feeder 
cells and with LIF (Leukemia inhibitory factor) to maintain their pluripotency. To induce 
differentiation, ES cells were plated on gelatine coated dishes without feeders or 
cultured in suspension. 
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4.3.1 The WAVE complex in CyFIP1 knockout ES cells is reduced 
After being generated, the ES cells were first characterized by analyzing the 
expression of CyFIP1 and the other components of the WAVE complex in total cell 
extracts, in order to establish if there was any biochemical difference. 
In all CyFIP1-/- ES cells no CyFIP1 protein could be detected, as expected (figure 22). 
The faint band visible in the WB could likely be ascribed to the feeder cells, which 
normally represent a 10% of the lysate. Also no CyFIP2 was expressed at this stage. 
Nap1, the direct interaction partner of CyFIP1 in the WAVE complex, was strongly 
down-regulated as well as WAVE2 and Abi2, which seemed to be the dominant Abi 
form in ES cells. Abi1 and WAVE1 appeared to be less expressed, compared to brain 
control, but equally affected by the loss of CyFIP1.  
Vinculin, a cytoskeletal adapter protein and FAK, the Focal Adhesion Kinase, which 
both play a role in focal adhesions, showed no differences between wt and knockout 
cells. SOS1 a binding partner of Abi1 in a different complex (Fan and Goff 2000) was 
not affected in the knockout. Total actin levels also did not appear to be altered by 
Western Blotting. 
In summary, the major biochemical alterations that could be identified in ES cells 
depleted of CyFIP1 concerned the WAVE complex. 
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Figure 22: Expression of the WAVE complex components in CyFIP1 knockout ES cells total protein 
extracts. Deletion of CyFIP1 resulted in a significant reduction of the complex subunits Nap1, WAVE1, WAVE2, 
Abi1 and Abi2. SOS1, Vinculin, FAK and Actin seemed not to be affected by CyFIP1 depletion. γ-Tubulin is used 
as reference gene. 
 
4.3.2 Genome-wide expression studies 
To obtain a comprehensive insight about the genes and the pathways altered in 
CyFIP1 ko ES cells and their differentiation, an RNA microarray approach was 
performed. Microarrays, a high-throughput method, allow generating massive amounts 
4. Results 
73 
 
of molecular biology data. Three different clones for each genotype of undifferentiated 
ES cells and ES cells cultured for 3 days on gelatine were analyzed on beadchip arrays 
containing more than 29000 annotated genes. Two main strategies were followed in 
data analysis: 1) Identifying the differentially expressed transcripts at the level of 
individual genes; and 2) Assessing the differential expression of transcripts grouped 
into modules related to functional pathways. In order to consider a single gene 
differentially expressed, it had to fulfill a dual-criterion of magnitude change over 
reference (arbitrary minimum fold change (FC) ±1.5) and statistical significance of 
p<0.05. For gene group analyses, the expression distribution of the whole gene group 
had to be significantly different between the control and knockout (p<0.05). All data 
were log2 transformed because log-transformation decouples a random multiplicative 
error from a true signal.  
 
4.3.2.1 CyFIP1 and CyFIP2 mRNA expression in wt and knockout 
undifferentiated and gelatine-differentiated ES cells 
First, expression levels of CyFIP1 and CyFIP2 mRNAs were analyzed. CyFIP1 mRNA 
expression in the knockout cells was only 2/3 of the wt. This could be explained by the 
fact that although exons 4-6 are deleted, the other exons are still in place, so an mRNA 
could be transcribed. Although it should be prevented from nuclear export by the NMD 
(non-sense mediated decay) mechanism, a leakage is always possible. However no 
functional CyFIP1 protein could be translated and was ever detected, as shown, for 
example, in figure 22. CyFIP1 mRNA expression levels did not differ between ES cells 
and differentiated cells, both in the wt and the knockout genetic background.  
On the contrary, CyFIP2 mRNA expression was affected by the knockout of CyFIP1. 
CyFIP2 in wt ES cells was low. Interestingly, in CyFIP1-/- ES cells CyFIP2 expression 
was about 20% higher than in the wt cells (figure 23). In the wt differentiated ES cells, 
after three days on gelatine, the expression of CYFIP2 increased about 1.5 fold in 
comparison to ES cells. The expression of CyFIP2 in CyFIP1-/- differentiated cells 
increased only slightly compared to undifferentiated cells and remained less than in wt 
cells. 
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Figure 23: Log2 transformed expression levels of CyFIP1 and CyFIP2 mRNA. The triplicates for every 
genotype and condition are shown as circles in different colors. Each circle represents one cell clone. Expression 
level of CyFIP1 in the knockout is only 2/3 of wt level. CyFIP1 expression did not change between ES cells and 
differentiated cells. CyFIP2 expression is affected by the knockout of CyFIP1 and increases during differentiation 
only in wt background. wt-0 (green): Wild type ES cells; ko-0 (red): CyFIP1-/- ES cells; wt-3 (purple): 
Differentiated wild type ES cells for 3 days on gelatine; ko-3 (blue): Differentiated CyFIP1-/- ES cells for 3 days 
on gelatine. 
 
4.3.2.2 Transcription factors altered by CyFIP1 deletion 
The mainly phenomenological data generated by microarrays are often difficult to 
relate with the activation/inhibition of particular signal transduction pathways. The gene 
expression changes measured using microarrays in different cellular states, in fact, 
reflect just an "echo" of real molecular processes in the cells. A way to facilitate data 
interpretation is to look for transcription factors. Transcription factors are essential for 
the regulation of gene expression. They are proteins that control which genes are 
turned on or off in the genome by binding to DNA and other proteins. Bound to DNA, 
these proteins can promote or block the gene transcription holoenzyme, increasing or 
decreasing the availability of specific mRNAs. In CyFIP1-/- ES cells eleven 
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transcription factors were found significantly up-regulated and one transcription factor 
was significantly down-regulated compared to wild type ES cells (figure 24).  
 
 
Figure 24: Gene expression heat map of transcription factors affected by CyFIP1 deletion in ES cells. 
The heat map displays (A) significantly up-regulated genes in 3 wild type ES cell clones (blue) compared to  
CyFIP1-/- ES cell clones (red) (B) significantly down-regulated genes in 3 CyFIP1-/- ES cell clones (blue) 
compared to 3 wild type ES cell clones (red). 
 
Among the up-regulated transcription factors, Tgif1 and Hmgb2 are known to play an 
important role in embryonic development and germ layer formation (Rodriguez, Velkey 
et al. 2007; Powers, Taniguchi et al. 2010; Abraham, Bronstein et al. 2013). Rnf4 
(RING finger protein 4), Atf4 (Activating transcription factor 4) and Hmga1 are known 
to play a positive role in regulating proliferation (Li and Wang 2006; Wang, Lian et al. 
2009; Wang, Qian et al. 2010; Hirota, Tsuda et al. 2014). Hmga1 also has role in 
cancer and tumor invasiveness (Wang, Qian et al. 2010). Ctbp2 ability to direct cell 
migration has been previously linked to its ability to repress PTEN expression and 
thereby stimulate phosphatidylinositol 3-kinase (PI3K) activity, resulting in Rac-
dependent migration (Paliwal, Kovi et al. 2007). Ctbp2 and Ndel1 are known to play a 
role in adhesion. Ndel1 is essential for cell proliferation and cell survival (Sasaki, Mori 
et al. 2005). Rbbp7 seems to play a role in differentiation and proliferation but more in 
the opposite direction compared to Rnf4 and Atf4: it inhibits cell growth by negatively 
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regulating β-catenin expression and the β-catenin/TCF signaling pathway, presumably 
through positive regulation of GSK-3 expression (Li and Wang 2006). Rbbp7 can 
induce apoptosis through activation of the c-Jun N-terminal kinase (JNK) signaling 
pathway (Zhang, Yu et al. 2003). Med24 is a component of the mediator complex (also 
known as TRAP, SMCC, DRIP, or ARC), a transcriptional coactivator complex thought 
to be required for the expression of almost all genes (Gustafsson and Samuelsson 
2001). Med24 is also discussed in the hematopoietic system and for Med1 it is shown 
that it has influence on the hematopoietic stem cells (Stumpf, Waskow et al. 2006) and 
that Med1-/- bone marrow cells proliferate less (Sumitomo, Ishino et al. 2010). Snrpa 
is essential for splicing and is present in the spliceosome associated with Sm complex 
(Hetzer and Mattaj 2000). Bcor is a transcriptional corepressor and is a key 
transcriptional regulator during early embryogenesis (Ng, Thakker et al. 2004). 
Rnf2 is the only significantly down-regulated transcription factor in CyFIP1-/- ES cells. 
Rnf2 is an essential component of a Polycomb group (PcG) multiprotein PRC1-like 
complex, a complex class required to maintain the transcriptionally repressive state of 
many genes, including Hox genes, throughout development.  
In differentiated cells after 3 days on gelatine only one transcription factor was found 
to be significantly up-regulated, Rhox9, and no one was significantly down-regulated 
compared to wt cells (figure 25).  Rhox 9 is a member of the Homeobox gene family 
and important in embryonic development and the reproductive system (Lee, Lee et al. 
2013), which is affected already in the CyFIP1+/- mouse (see results 4.1 and 4.2). In 
hematopoietic stem cells Rhox9 is highly expressed compared to endothelial cells 
(Solaimani Kartalaei, Yamada-Inagawa et al. 2015) 
 
 
Figure 25: Gene expression heat map of transcription factors affected by CyFIP1 deletion in 
differentiated cells. The heat map displays one significantly up-regulated gene in 3 CyFIP1-/- cell clones 
differentiated for 3 days on gelatine compared to 3 wild type differentiated cell clones. No significant down-
regulated genes were found. 
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4.3.2.3 Pathway enrichment analysis in CyFIP1-/- ES cells 
Pathway enrichment analysis (PEA) was used to identify statistically significant gene 
sets affected by the deletion of CyFIP1. Interestingly, among others, the PI3K-Akt 
signaling pathway appeared up-regulated in the absence of CyFIP1 (figure 26). The 
PI3K-Akt signaling pathway is involved in a wide variety of cellular events including 
mitogenic signaling, regulation of growth and survival, vesicular trafficking, and control 
of the cytoskeleton.  
 
 
Figure 26: Pathway enrichment analysis in CyFIP1 knockout vs. wt ES cells: up-regulated pathways. 
Significantly up-regulated gene sets/pathways are shown with the enrichment Score and p-value.  
 
No significant differences resulted for the PEA of the entire TGFβ pathway in  
CyFIP1-/- ES cells in comparison to the wt cells, but the overview heat map of the 
pathway with all TGFβ genes showed clear differences in expression levels of a subset 
of genes (figure 27). For example one can see in the bottom half of the map Smad5, 
Smad2 and Nodal are down in the CyFIP1-/- ES cells compared to wild type ES cells. 
The TGFβ superfamily is known to be one of the most ubiquitous regulators of 
embryonic development (Gordon and Blobe 2008). For example it regulates germ layer 
formation via the BMP/Smad signaling (Coucouvanis and Martin 1999; Pangas, Li et 
al. 2008). Because of the early embryonic phenotype of the CyFIP1 knockout it seemed 
a plausible candidate pathway that could be affected by CyFIP1 depletion. 
4. Results 
78 
 
 
Figure 27: Gene expression heat map of TGFβ superfamily genes affected by CyFIP1 deletion. Heat map 
of all genes involved in the TGFβ network in the 3 CyFIP1-/- ES cell clones compared to the 3 wild type ES cell 
clones. A clear difference is observed in the bottom half of the map, besides some dysregulation of some of the 
genes in the upper part of the map. 
 
In summary the microarray analysis showed that transcription factors mRNAs as well 
as pathways involved in apoptosis, cell growth, proliferation, adhesion and 
transcription are significantly up-regulated in CyFIP1 knockout cells. Also genes which 
are important in development and differentiation were significant altered in the  
CyFIP1-/- cells. These findings represented a starting point for further analysis of the 
mutant ES cells to experimentally verify any defects in apoptosis, proliferation, 
differentiation and adhesion. 
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4.4 Proliferation and adhesion properties of CyFIP1-/- ES 
cells 
The microarray data for the CyFIP1-/- ES cells showed altered mRNA levels of 
transcription factors which regulate cell proliferation and adhesion. Proliferation and 
adhesion are important functions in cells and are necessary for the cell and the whole 
organism survival. To check proliferation and adhesion in CyFIP1-/- ES cells the so 
called CyQuant assay was used. Proliferation and adhesion can be easily and 
reproducibly measured with this assay because it is based on counting the cells that 
grow on plates using DNA quantification as a measure to determine the number of 
cells. The CyQuant dye intercalating nucleic acids was quantified by fluorometric 
measurement. For the proliferation assay, ES cells were grown on feeders for five days 
and every day a plate was frozen for quantification. At the end of the time course all 
plates were stained and read together in a plate reader. A second protocol was used 
to study combined adhesion and proliferation properties by growing ES cells for five 
days on gelatine without feeders. Adhesion capacity was examined after seeding equal 
numbers of ES cells on gelatine, a collagen-derived substrate, with a short time course, 
freezing one plate every hour for a total of 4 hours.  
In the proliferation assay, Cyfip1-/- ES cells rapidly grew into a stationary phase where 
probably the proliferation rate was equal to the apoptosis rate, the two processes 
balancing each other. Instead, wt ES cells grew slower and after reaching maximal 
density underwent cell death with a net decrease in cell number (figure 28A). Indeed, 
while handling the ES cells for the experiments, it was always necessary to passage 
CyFIP1-/- ES cell clones earlier than wt clones although the same number of cells was 
plated on the dish.  
In a different proliferation protocol on a collagen substrate the results were very 
different. While wt cells proliferated massively, up to 100 times the initial adhered 
number (although this high increase could be partially due to the zero time point 
preparation, where simple centrifugation of the cells on collagen might not efficiently 
adhere all seeded cells), CyFIP1-/- cells were 4 to 5 times slower (figure 28B).  
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Figure 28: Proliferation 
and adhesion properties 
of CyFIP1-/- ES cells. (A) 
CyFIP1-/- ES cells showed 
an increased proliferation 
rate, as seen by the steeper 
slope, reaching steady state 
after three days on feeders 
(B) Without feeders wild 
type ES cells proliferated 
very efficiently while 
CyFIP1-/- ES cells were 
much slower. (C) CyFIP1-/- 
ES cells showed deficits in 
adhesion to collagen.  
 
 
Analyzing raw numbers showed a much smaller number of CyFIP1-/- cells at every 
time point compared to wt, possibly indicating adhesion deficits on the collagen 
substrate, or a requirement of growth factors from feeder cells, or a cell density effect, 
or a combination of all factors that could all justify the different result from the previous 
experiment. 
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For this reason, the adhesion capacity of CyFIP1-/- ES cells on a collagen-derived 
substrate was tested and it was found reduced in the first 4 hours after plating, although 
only by a factor of about 2 (figure 28C). This was in line with the previous experiment, 
partially explaining the low growth on gelatine, since cells might be continuously lost in 
the medium due to adhesion deficits. But the much larger effect observed in the cell 
proliferation assay implies other reasons, as proposed above. 
 
 
4.5 Morphological characterization of CyFIP1 knockout 
embryoid bodies  
The morphological analysis of CyFIP1-/- embryos showed defects in development at 
the time point of gastrulation (see Introduction 1.7.2). The microarray data provided 
some hints concerning differentiation and germ layer formation. Genes from the TGF 
beta pathway like Smad 1 and 5, which have been shown to be important for 
mesoderm formation and for endoderm organization in the embryo were affected. The 
up-regulation of the transcription factors Tgif1 and Hmgb2 in CyFIP1-/- ES cells also 
suggested possible germ layer formation defects. For a detailed analysis of germ 
layers, an in vitro differentiation system was chosen, the embryoid body formation from 
ES cells, due to its sustainability compared to embryo analysis that would require a 
high rate of animal sacrifice. It is a well-established protocol where ES cells cultured in 
suspension without anti-differentiation factors spontaneously differentiate and form 
three-dimensional multicellular aggregates called embryoid bodies (EBs) (Nishimura, 
Martin et al. 2007). In the EBs, the three embryonic germ layers, ectoderm, endoderm 
and mesoderm, are developed. EBs grossly resemble early embryos at the blastocyst-
primitive streak stage (see Introduction 1.11), having an endodermal exterior and a 
mesodermal and ectodermal interior. Furthermore, the cells of the EBs are surrounded 
by a large cystic yolk sac-like cavity. Accordingly, the outer columnar epithelium is of 
endodermal origin (visceral endoderm). This model system, therefore, allows to study 
early developmental stages in vitro. 
In a first approach, in order to morphologically characterize them, EBs obtained from 
wt and CyFIP1-/- ES cells were imaged in wide field microscopy and measured. 
Evident differences could be detected in their size. Cyfip1-/- EBs were significantly 
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larger than control EBs (figure 29), suggesting that Cyfip1-/- cells have a higher 
proliferative activity, in line with the previous proliferation assay (see figure 28A).  
 
 
Figure 29: Comparison between wild type and CyFIP1-/- EBs after 7 days of differentiation. H&E Staining 
of (A) wt and (B) CyFIP1-/- EBs showed that mutant EBs are much bigger than wt controls. 
 
4.5.1 Germ layers defects in CyFIP1-/- EBs 
The question, therefore, was what could be wrong in the development of the mutant 
EBs. Were all layers present with increased cell numbers, or were some layers missing 
to the expense of other layers, or would there be no layering at all? Germ layers can 
be identified by specific markers. CD184 is known to be expressed in endodermal cells 
(Drukker, Tang et al. 2012) while beta-catenin is important for meso-endoderm 
formation through the Wnt-signaling pathway (Davidson, Adams et al. 2012). Cleaved 
caspase 3 is expressed during apoptosis and can mark the cell death rate in the 
blastocoele-like cavity of EBs (Porter and Janicke 1999). To address the question how 
the germ layer formation in CyFIP1-/- is affected, a quantitative FACS-based method 
was developed to analyze differentiation of individual cell lineages in CyFIP1-/- versus 
wt EBs. Flow cytometry has the advantage that many cells can be analyzed in a short 
time and quantitative data were obtained. EBs were generated from three independent 
clones of CyFIP1-/- and wild type (wt) ES cells after 7 days in suspension culture. They 
were then collected and a single cell suspension was produced with a gentle 
dissociation treatment. Cells were then immunostained with fluorescently-labeled 
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primary antibodies raised against the germ layers markers described above and 
analyzed with a BD Accuri flow cytometer. 
The results of this analysis showed that CyFIP1-/- EBs were impaired in their 
differentiation program. In fact the endoderm showed a significant 40% expansion, 
while the meso-endoderm was decreased by 20% in comparison to wt EBs (figure 
30A,B). Moreover, the apoptosis rate was increased by 60% in CyFIP1-/- EBs (figure 
30C). 
In summary, these data showed a considerable impairment of mesodermal lineage 
determination in Cyfip1-/- EBs while the endodermal lineage was found to be increased 
at the expense of mesodermal cells and EB size. Ectoderm seemed not to be 
influenced in the knockout, but it represented a very small percentage of cells in EBs 
(data not shown). 
 
 
 
Figure 30: Quantification of endoderm, meso-endoderm and apoptosis in CyFIP1 knockout embryoid 
bodies. Flow cytometric analysis from 7 days old embryoid bodies. Results are displayed as fold increase (>1) 
or decrease (<1) respect to wt controls. (A) Significant increase of endodermal cells in CyFIP1-/- EBs. (B) The 
amount of mesodermal cells is significantly decreased in CyFIP1-/- EBs. (C) CyFIP1-/- EBs show a much higher 
number of apoptotic cells. For each genotype, n=3 (independent ES clones). Statistical analysis by T-test: ** 
P<0.01, *** P<0.001. 
 
 
4.6 Differentiation of CyFIP1-/- ES cells on gelatine 
While EBs formation reproduces a directed differentiation into the three germ layers, 
another approach to study differentiation is undirected differentiation of ES cells on a 
substrate, for example culturing ES cells for 3 days on gelatine without feeders in 
regular ES cell culture medium. This simple differentiation protocol was used also for 
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the microarray analysis, therefore it appeared necessary to study it from a 
morphological and biochemical point of view.  
The wild type ES cells, despite the presence of the LIF, directly started to differentiate. 
In fact, under these conditions, they lost the typical round shape of the colonies, spread 
out and flattened. The CyFIP1-/- cells, on the contrary, mostly kept the round colony 
form and differentiated much less (figure 31). Even after 3 days on gelatine they looked 
more like ES cell clones compared to the wt where no single clone could be detected. 
 
 
Figure 31: Wide field imaging of wild type and CyFIP1-/- ES cells after 3 days in culture on gelatine. 
CyFIP1-/- ES cell colonies were resistant to differentiation after 3 days in culture without feeder layer. 
 
4.6.1 Molecular characterization of CyFIP1-/- ES cells on gelatine 
As it was shown by visual analysis (4.6 and figure 31), CyFIP1-/- ES cells differentiated 
less than wt cells when cultured for three days on gelatine. To characterize the type of 
cells which were growing on the collagen-like surface, two markers were used: SSEA1, 
Stage-Specific Embryonic Antigen 1, a well-known marker for murine pluripotent stem 
cells (Ginis, Luo et al. 2004) and Sca-1, Stem cell antigen-1, a member of the Ly-6 
antigen family in mouse expressed in hematopoietic stem/progenitor cells (Holmes and 
Stanford 2007). The cultured cells were detached from the plate, brought to a single-
cell suspension, and analyzed by FACS after labeling them with the stem cell markers. 
This method, as previously mentioned, provides reliable quantitative data.  
CyFIP1-/- cultures were tendentially richer in SSEA1 positive cells (figure 32A), 
indicating the presence of more stem cell-like cells than in the wt culture. This is in 
good accordance with the previous findings obtained analyzing the morphology of the 
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colonies on the dish. In addition, Sca-1 positive cells were significantly decreased in 
CyFIP1-/- cultures (figure 32B). Hematopoietic stem cells are the progenitor cells that 
give rise to all blood and immune cells and are derived from the mesodermal lineage. 
It was already shown using an in vitro embryo developmental paradigm that CyFIP1-/- 
ES cells are defective in mesoderm formation (see Results 4.5.1 and figure 30B), and 
these data strongly confirm the previous findings.  
 
 
Figure 32: Quantification of different types of stem cells after culturing CyFIP1 knockout ES cells on 
gelatine. A) SSEA1, a stem cell marker, is increased in CyFIP1-/- cultures. B) Sca-1, a hematopoietic stem cell 
marker, is significantly decreased in CyFIP1-/- cultures. N=3 for each genotype. Statistical analysis with t-
student’s test: *** p<0.001. 
 
 
4.7 Analysis of kinases involved in growth, survival and 
apoptosis pathways  
Proliferation, cell growth and adhesion have been shown to be altered in CyFIP1-/- ES 
cells. These cell functions, when abnormal, play an important role in cancer formation 
and progression, therefore it appeared a key question to identify the signaling 
pathways responsible for the described phenotype. The microarray data showed an 
overall increase of the PI3K pathway in CyFIP1-/- ES cells. The PI3K pathway 
regulates many cell functions such as proliferation, cell growth and adhesion and 
consequently its dysregulation is also the main known cancer pathway. Nevertheless, 
the MAPK pathway also regulates cell proliferation and survival and is another 
A B 
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important cancer pathway in case of alterations. The TGFβ pathway controls apoptosis 
and proliferation, also resulting to have a role in cancer when altered. Important 
proteins of the TGFβ pathway are the Smads. Smads are intracellular proteins that 
transduce extracellular signals from TGF ligands to the nucleus where they activate 
downstream gene transcription (Heldin, Miyazono et al. 1997). Smad1/5 and also 8 
have been shown to be important in early embryonic development (Faure, Lee et al. 
2000).  
The activity of these pathways correlates with the phosphorylation state of many of 
their components. Therefore, the phosphorylation state of key proteins of these 
pathways was analyzed by western blotting in cell extracts from ES cells grown on 
feeders to possibly uncover the molecular mechanisms leading to the defects 
described in the previous sections when CyFIP1 is depleted. 
Western Blot analysis of PI3K, MAPK and TGFβ pathways related proteins showed no 
clearly visible differences in protein levels (figure 33A). Therefore a statistical approach 
was adopted, quantifying the protein levels in the three clones and calibrating with the 
-tubulin expression, to detect even subtle changes in the protein levels. The analysis 
showed only a significant decrease of phospho-Smad1/5 in CyFIP1-/- ES cells (figure 
33 B). All other proteins showed no significant differences between wt and CyFIP1-/- 
ES cells. Only tendencies were visible. The PI3K pathway appeared down-regulated 
at the protein level in CyFIP1-/- compared to wt ES cells, in contradiction with the 
microarray analysis. A tendential down-regulation was also seen for phospho-Erk1 and 
phospho-Erk2 although data showed high variability among the three clones (figure 
33B). 
In summary, the analysis showed that P-Smad1/5 are significantly decreased, while 
the PI3K pathway as well as the MAPK pathway are overall not significantly affected. 
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Figure 33: Total protein and phosphorylated protein levels of components of the PI3K, MAPK and TGFβ 
pathways. A) Western Blotting of selected components of the PI3K, MAPK and TGFβ pathways of wt and 
CyFIP1-/- ES cell clones. γ-Tubulin is shown as reference gene. B) Quantification analysis of total and 
phosphorylated protein levels showed significant decrease of phospho-Smad1/5 levels in CyFIP1-/- ES cells. No 
significant changes could be observed in the other proteins. Only a tendential decrease could be seen in the 
proteins which were related to the PI3K pathway and the phosphorylated MAPKs in CyFIP1-/- ES cells. Data 
were calibrated with γ-Tubulin levels and are expressed as means ± SEM; n = 3 per genotype. Statistical analysis 
with t-student’s test: *p < 0.05 
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4.8 Biochemical Analysis of the WAVE Complex(es) in the 
Mouse 
The WAVE complex is composed by the different isoforms of its 5 subunits but may be 
closely interacting with other unknown factors in order to be regulated in its activities. 
In this way the WAVE complex composition and function might be differently specified 
in different tissues. As mentioned in the introduction, Cyfip1/2 interacts with Profilin2 
but not with Profilin1 (Witke, Podtelejnikov et al. 1998). The interaction of Profilin2 and 
the WAVE complex depends on the poly-L-proline binding domain of Profilin2 (Witke, 
Podtelejnikov et al. 1998). In pull-down assays with Profilin2-beads nearly all CyFIP1/2 
is collected from brain lysates (Massimi 2008). Pull-down assays are useful for 
identifying the domains or post-translational regulatory mechanisms affecting protein-
protein interactions and for identifying previously unknown binding partners by mass 
spectrometry sequencing of the pulled-down proteins.  
Pull-down assays with Profilin2-beads were used in this thesis to investigate the 
question of subunit exchange and the regulatory mechanisms of the WAVE complex. 
  
 Figure 34: Scheme of a Profilin2 pull-
down experiment. Profilin2 covalently 
bound to Sepharose 4B beads interacts 
with the WAVE complex when the beads 
are mixed with a mouse tissue lysate 
extracting it with its ligands from the total 
protein pool (Witke, Podtelejnikov et al. 
1998)). 
 
 
4.8.1 The WAVE complex in mouse tissues 
Most WAVE complex subunits are represented by more than one isoform, which have 
a tissue specific pattern, with an expression overlap in some tissues. It is, therefore, 
possible to hypothesize that in every tissue one or more unique WAVE complexes are 
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formed. Pull-down assays with Profilin2-beads from brain, lung and kidney lysates 
were performed in order to dissect some of these complexes. In brain and lung the 
amount of free subunits (unbound fraction) was rather low and practically all of the 
subunits appear to be forming WAVE complexes bound to profilin2 (figure 35). In brain 
the complex incorporated essentially WAVE1, while in lungs only WAVE2 formed the 
complex, due to the different expression patterns of the WAVE subunits.  
Surprisingly the WAVE complex in the kidney behaved differently from the other 
tissues. First of all in kidney the WAVE complex didn’t bind to Profilin2 (figure 35). 
Secondly, no Abi1 was expressed (figure 35), implying that probably Abi2 is the main 
Abi component in kidney’s WAVE complex, even though Abi2 has been characterized 
as the brain isoform (Grove et al., 2004).  
 
 
Figure 35: Different properties of the WAVE complex in brain, lungs and kidney. In brain and lungs the 
classical WAVE complex binds to Profilin2-beads. In kidney the WAVE complex doesn´t bind to Profilin2.  
 
4.8.2 The WAVE complex regulation by different ionic conditions 
and signaling pathways 
An interesting question is if the composition of the WAVE complex could change in 
response to different ionic conditions and signaling pathways. In order to address this 
question, Profilin2 pull-down assays were performed with different lysis buffers 
covering a range of conditions and signaling cascades. The control condition was a 
basic isotonic buffer with KCl, Tris/HCl pH 7.4 to keep the lysate buffered and TritonX-
100 to lysate the tissues. The other buffers consisted of the basic buffer components 
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and some additional reagents: the second buffer was enriched in Mg2+ without Ca2+. 
The absence of any free Ca2+ was ensured by the use of EGTA, which binds uniquely 
to Ca2+, negatively affecting Ca2+-dependent interactions and pathways. The third 
buffer, on the contrary, was enriched in both Mg2+ and Ca2+ and should therefore 
activate Ca2+-dependent pathways. The fourth lysate was depleted of all divalent ions 
by using the strong wide spectrum chelator EDTA. The fifth type of lysate was depleted 
of all protein phosphorylation by digestion with CIP (calf intestinal phosphatase). The 
sixth one, was prepared with strong phosphatase inhibitors (NaF, Na3VO4 and Na-
pyrophosphate) to preserve the physiological phosphorylation state of proteins. NaF is 
inhibiting serine and threonine phosphatases (PSPs). Na3VO4 has a high resemblance 
to phosphate due to the four oxygen atoms in a tetrahedral conformation and can inhibit 
tyrosine phosphatases (PTPs) through competitive inhibition. Na-pyrophosphate on 
the other hand has a high resemblance to the end product of phosphorylation (although 
it is missing the adenosine part) and can also inhibit phosphatases through competitive 
inhibition.  
The results of the Profilin2 pull-down essay from brain extracts prepared in the different 
buffers are shown in figure 36. The bound fractions of each pull-down showed a 
surprisingly flexible composition of the WAVE complex. High Mg2+ in the absence of 
Ca2+ led to a strong binding of the entire WAVE complex to Profilin2 (column 2 vs. 1), 
whereas the addition of Ca2+ resulted in no binding at all (column 3). Sequestration of 
all divalent cations from the solution obtained with the addition of EDTA resulted in a 
very surprising effect, the braking of the pentameric WAVE complex in two parts, with 
the CyFIP/Nap1 core binding alone to Profilin2 and the Abi/WAVE part left in the 
unbound fraction (column 4). Dephosphorylation of the proteins in the lysate seemed 
to have only little influence on the binding pattern of the WAVE complex components 
(column 5 vs. 1). Finally, even more surprisingly, preservation of the phosphorylation 
state of proteins seemed to detach exclusively Abi1 from the complex, and at the same 
time to increase the binding of the CyFIP/Nap1 core similarly to when all divalent 
cations were removed by the addition of EDTA.  
These results strongly pointed to a flexibility in the composition of the WAVE complex 
that in brain can also exist as a CyFIP/Nap1 complex alone or a CyFIP/Nap1/WAVE1 
complex. 
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Figure 36: Differential composition of the WAVE complex binding to Profilin2 in different buffer 
conditions. Western blotting showing in Column 1 the binding of the WAVE complex in a basic isotonic buffer 
with 1% TritonX-100 for reference of the other columns; in Column 2 increased binding of the WAVE complex to 
Profilin2-beads in the presence of Mg2+ ions; in Column 3 loss of WAVE complex binding to Profilin2 in the 
presence of Ca2+; in Column 4 uncoupling of CyFIP/Nap1 and Abi/WAVE sub-complexes when all divalent ions 
are sequestered from the solution; in Column 5 that treatment of the lysate with phosphatase (removing all 
phosphorylations) does not significantly affect the binding of the WAVE complex to Profilin2; in Columns 6 that 
in the presence of phosphatase inhibitors the binding of CyFIP/Nap1 to Profilin2 is enhanced, while the Abi 
subunit is specifically lost. 
 
4.8.3 New candidate ligands of the WAVE complex 
Since the data presented until now have shown that the WAVE complex has a quite 
flexible structure, it was sensible to think it might be interacting with yet unknown 
partners. In order to verify this hypothesis, a new approach was designed. CyFIP1/2 
was immunoprecipitated from brain extracts with a specific monoclonal antibody 
previously generated and characterized in the lab (Massimi 2008) and new candidate 
ligands were identified by Maldi-TOF mass spectrometry after band elution from a 
polyacrylamide gel. Mass spectrometry is a technique that allows the identification of 
proteins by producing and separating ions by their unique mass-to-charge ratios. 
Although there is no possibility to distinguish if ligands directly interact with CyFIPs or 
with any of the other WAVE complex components, this approach allows at least 
identifying possible cellular processes in which the WAVE complex is involved and 
further expanding the current view of the WAVE complex as a static pentameric 
structure. 
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By mass spectrometry it was possible to identify among the immunoprecipitated 
material CyFIP1 and CyFIP2 as well as the classical complex components such as 
Nap1, Abi1/2 and WAVE1. Besides the WAVE complex, which was considered as a 
positive control for the whole experiment, many other possible novel ligands have been 
identified. For easiness of interpretation they are presented in figure 37 divided into 
four functional protein groups: actin-binding, membrane trafficking, signaling, and 
mRNA translation and transport.  
 
 
Figure 37: Novel candidate ligands for CyFIP1/2 and the WAVE complex identified by MALDI-TOF. The 
identified candidates are presented grouped according to four molecular pathways related to actin-binding, 
signaling, membrane trafficking and mRNA translation and transport. 
 
In the group of actin-binding proteins were found besides the expected Profilin2 (Witke, 
Podtelejnikov et al. 1998) and Arp2/3 complex some interesting novel candidates such 
as Cofilin 1 and CapZ (figure 37). Also, surprisingly, POF1 was identified, a protein 
mutated in human premature ovarian failure (Lacombe, Lee et al. 2006), an infertility 
phenotype that has been previously described in CyFIP1+/- females (see Results 4.1).  
Among the membrane trafficking-related candidates, Myosin 1 and Myosin 4 were 
found, possibly pointing to a role of the WAVE complex in actin-based cargo transport 
(confirmed by the candidates concerning mRNA transport).  
Interestingly proteins involved in translation initiation (e.g. eIF4A and eIF6) and mRNA 
transport in neurons (hnRNPA1, Pur-α) were also found, in line with the already shown 
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role of CyFIP1 in mRNA translational repression in spines in combination with FMRP 
(Napoli, Mercaldo et al. 2008).  
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5.1 Relevance of genetic background for CyFIP1 deletion  
The genetic background of the mouse is well known to dramatically influence the 
phenotype of single locus changes brought about by gene targeting. The influence of 
the genetic background is evident on the phenotype of the CyFIP1 knockout mouse 
model. The three strains used until now for this knockout show some substantial 
phenotypic differences. The widely used C57BL/6J and C57BL/6N strains are so-
called inbred mouse strains which were generated by sister-brother matings for 20 or 
more consecutive generations, respectively at the Jackson Laboratories and at NIH, 
hence the last letter in the name (Green, Grueneberg et al. 1963). They have a great 
genetic stability and were generated to facilitate the comparison of data from different 
labs. The CD1 mice are outbred stocks, which have genetic variability. Inbred strains 
offer a defined genetic background, whereas outbred stocks offer a diverse gene pool, 
which is closer to the situation in most human studies. In C57BL/6J background the 
CyFIP1 knockout is embryonic lethal around E8.5. The CyFIP1 knockout in C57BL/6N 
background showed a much more severe phenotype, with embryonic lethality 
occurring as early as E6.5 and the embryos quickly reabsorbed. Moreover, an infertility 
phenotype of the heterozygous females appeared, which complicates the 
embryological studies. The infertility phenotype becomes much milder in CyFIP1 
heterozygous females in the CD1 genetic background. In general, for embryological 
studies, the CD1 background is also much better, due to higher female fertility, better 
maternal behavior, and bigger litter size compared to the C57BL/6 strain. Therefore, 
the CD1 strain is ideal for studies where a high number of embryos is needed. 
Nevertheless, the lethality of the CyFIP1 knockout mouse in CD1 background occurred 
between E6.5 and E8.5, with the malformed mutant embryos still visible at E8.5, before 
being reabsorbed. The larger time range of embryonic death could be due the genetic 
variability of the outbred strain compared to the inbred C57BL/6. From the genetic point 
of view the two C57 strains were thought to be quite similar, but in the case of the 
CyFIP1 deletion a small genetic difference strongly affected the phenotype. More 
recent comparison of C57BL/6J and C57BL/6N demonstrated a range of genetic 
differences that have the potential to impact upon penetrance and expressivity of 
mutational effects in these strains. Sequence variants were identified which provide a 
set of candidate genes for the phenotypic differences observed between the two 
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strains (Simon, Greenaway et al. 2013). So the genetic background confirms being an 
important factor to consider when generating knockout mouse models. 
 
 
5.2 CyFIP1 as a tumor suppressor 
Cancer occurs when a dysregulation of important cellular processes like proliferation, 
apoptosis, differentiation and adhesion take place. A tumor suppressor is a gene that 
can control these important cellular processes in the direction opposite to carcinogenic 
alterations. CyFIP1 might indeed function as a tumor suppressor gene, as proposed in 
a previous report (Silva et al., 2009). Silva et al. published in 2009 that Cyfip1 is a 
putative invasion suppressor in epithelial cancers. They showed that CyFIP1 is deleted 
in human epithelial cancers and observed a reduced expression of Cyfip1 during 
invasion of epithelial tumors (Silva, Ezhkova et al. 2009). Silencing of WAVE complex 
components reduced cell-cell adhesion and adhesion to the extracellular matrix (Silva, 
Ezhkova et al. 2009). 
Upon deletion of both CyFIP1 alleles, in fact, ES cells gain proliferative capacity, lose 
adhesion to extracellular matrix and maintain an undifferentiated morphology for a 
longer time. In order to uncover the molecular pathways responsible for the phenotype, 
two approaches were employed in this work: 1. An unbiased high throughput analysis 
using microarrays; 2. A biochemical study of signaling pathways selected by their 
relevance in the processes altered in the CyFIP1-/- cells. Contrary to many 
expectations, classical pathways involved in cell proliferation and growth such as the 
MAPK and the PI3K pathways did not result significantly activated in the CyFIP1-/- 
cells at the protein level (although the PI3K pathway at the mRNA level appeared to 
be up-regulated). Instead, a specific signaling cascade within the TGFβ pathway was 
found significantly reduced. The TGFβ pathway is vast and widespread, with roles from 
embryo development to adult organisms, and is known to be involved in cancer (Grady 
2005). In particular Smad1/5, which are involved in TGFβ signaling, showed a 
significant reduction of their phosphorylation in CyFIP1-/- ES cells. It has been shown 
that conditional deletion of Smad1 and Smad5 in somatic cells of male and female 
gonads leads to metastatic tumor development in mice (Pangas, Li et al. 2008). The 
question is how CyFIP1 is connected to the TGFβ pathway. Experiments with CyFIP1 
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-/- ES cells in a special medium (Esgro, Millipore) to grow these cells without feeders 
and serum free showed a reduction of the CyFIP1-/- phenotype (data not shown). In 
these conditions ES cells reverted to nearly normal proliferation rates and EBs 
differentiated properly. This medium contains BMP4 and a GSK3β inhibitor. GSK3 
(Glycogen synthase kinase-3) is a target of Akt and is known to play important roles in 
numerous signaling pathways that regulate a variety of cellular processes including 
cell proliferation, differentiation, apoptosis and embryonic development (Xu, Kim et al. 
2009). In the microarray analysis only a non-significant up-regulation of GSK3 could 
be detected, but protein and phosphorylation levels have not yet been analyzed. BMP4 
is an extracellular signaling molecule of the TGF superfamily of ligands that binds to 
heterodimeric complexes of type I and type II cell surface receptors (BMPRI and 
BMPRII), which in turn leads to phosphorylation of Smad1/5/8 (Ueki and Reh 2012). 
As mentioned before, in CyFIP1-/- ES cell a significant decrease in phosphorylation of 
Smad1/5 was observed, but the Esgro medium was able to rescue it. Therefore CyFIP1 
must have a direct or indirect influence on the phosphorylation of the Smads. The gene 
Nipa1 is often found together with CyFIP1 as an autism risk gene because in human 
they are both in the 15q11.2 region (Doornbos, Sikkema-Raddatz et al. 2009). This 
region has been implicated in autism spectrum disorders (ASDs) associated with 
15q13.2microduplication (van der Zwaag et al., 2009) and 15q11-q13 deletion at break 
points 1 and 3 in Prader-Willi and Angelman syndromes (Moreira, Griesi-Oliveira et al. 
2014). This region encodes four genes: CyFIP, TUBGCP5, Nipa1 and Nipa2 (Murthy, 
Nygren et al. 2007). TUBGCP5, the Tubulin Gamma Complex Associated Protein 5 is 
a member of the gamma-tubulin complex which is a large multiprotein complex that is 
required for microtubule nucleation at the centrosome (Murphy, Preble et al. 2001). 
Nipa family members are integral membrane proteins which function as magnesium 
transporters (Xie, Zhang et al. 2014). Nipa1, Nipa3 and Nipa4 transport Mg2+ as well 
as other cations. Nipa2 is a highly selective magnesium transporter located in the 
cytomembrane and the early endosome (Goytain, Hines et al. 2008). Its function is to 
transfer extracellular Mg2+ into the cytoplasm (Quamme 2010). Nipa1 is also known to 
be an inhibitor of BMP signaling by interacting with the type II BMP receptor (Tsang, 
Edwards et al. 2009), although it is not known how Nipa1 itself is regulated. It was 
shown in cell culture experiments on human embryonic stem cells, that high 
concentration of magnesium in the medium resulted increased proliferation and 
increased apoptosis of the cells (Nguyen, Garcia et al. 2012). Low or high magnesium 
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concentrations in the cytoplasm are diverse discussed in the cancer field. It is well 
established that intracellular magnesium concentrations affect functions directly linked 
to those identified as the hallmarks of cancer (Hanahan and Weinberg 2000; Hanahan 
and Weinberg 2011). One can hypothesize that Nipa1 and/or Nipa2 are negatively 
regulated by CyFIP1. This hypothesis needs to be confirmed with further experiments.  
Finally, many transcription factors found up-regulated in CyFIP1-/- ES cells by the 
unbiased microarray screening presented in this thesis are connected to cancer. 
HMGA1 was found to be overexpressed in pancreatic adenocarcinomas (Liau, Jazag 
et al. 2007) and overexpression of HMGB2 was shown to be associated with tumor 
aggressiveness and prognosis of hepatocellular carcinoma (Kwon, Kim et al. 2010). 
Atf4 is overexpressed in human solid tumors, suggesting that it has an important 
function in tumor progression (Ye, Kumanova et al. 2010). TGIF1 splicing variant 8 
was found overexpressed oral squamous cell carcinoma and is related to pathological 
and clinical behavior (Liborio, Ferreira et al. 2013). CtBP2 was shown to be 
overexpressed in colon, breast, and prostate cancer (Thomas, Jacobs et al. 2008), and 
increased levels have been linked to the loss of tumor suppressors such as APC, 
Hipk2, and ARF (alternative reading frame) (Ng, Thakker et al. 2004). An hypothesis 
that could explain the up-regulation of this panel of transcription factors involved in cell 
proliferation and adhesion, and consequently in cancer progression and invasiveness, 
could be that the suppression of the TGF pathway reduces the competition with the 
MAPK and PI3K pathways, which can take over, although the increase in transcription 
factor level should be verified at the protein level, as well as their translocation to the 
nuclear compartment. 
 
 
5.3 Functions of CyFIP1 in embryonic development and 
cellular processes  
Homozygous deletion of CyFIP1 resulted in an early embryonic lethal phenotype 
between E6.5 and E8.5. Most homozygous embryos appeared to die of severe defects 
in gastrulation and were quickly reabsorbed. Indeed, differentiation studies of ES cells 
into embryoid bodies showed substantial expansion of the endoderm, partially also at 
the expense of mesodermal differentiation. The formation of the primitive streak, of 
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meso-endodermal nature, is the important starting point of gastrulation in embryonic 
development. 
These considerations also explain previous observations on CyFIP1-/- embryonic 
developmental alterations in the C57Bl/6J background (Massimi 2008). Massimi 
reported that CyFIP1 ko embryos have defects in somite formation, neural tube closure 
and anterior-posterior axis formation. These structures are of mesodermal origin or are 
induced by mesoderm formation. For example, the formation of the neural plate begins 
when the dorsal mesoderm signals to the ectodermal cells above it to elongate into 
columnar neural plate cells (Keller, Shih et al. 1992). Members of the TGFβ family of 
secreted growth factors regulate key processes during postimplantation mammalian 
development including embryonic axis patterning, organogenesis and specification of 
the germ line. 
CyFIP1 controls important cell functions like proliferation, adhesion, differentiation and 
apoptosis. In CyFIP1-/- ES cells hyper-proliferation was observed and adhesion is 
impaired. CyFIP1-/- EBs show increased apoptosis rate and disturbed differentiation 
into mesoderm. CyFIP1-/- ES cells which were differentiated for three days on gelatine 
showed a more stem cell-like morphology and also the analysis of the molecular 
markers in these cells showed a defect of differentiation into hematopoietic cells, which 
are of mesodermal origin.  
Transcription factors regulating proliferation and differentiation were found affected 
using a microarray approach. The transcription factor RNF4 is up-regulated in  
CyFIP-/- ES cells. It was shown that disruption of the RNF4 gene in chicken DT40 cells 
resulted in a gradual loss of proliferation capability (Hirota, Tsuda et al. 2014). The 
experiments performed on ES cells in this work showed a higher proliferation rate in 
the absence of CyFIP1. In CyFIP1-/- ES cells the transcription factor HMGB2 is 
significantly up-regulated. HMGB2, the high mobility group box 2, is a member of the 
non-histone chromosomal high-mobility group protein family. Interestingly, the 
transcription factor is known to regulate Oct4, a stem cell marker that is important in 
embryonic development. The knockout of HMGB2 in the sub-granular zone showed a 
down-regulation of Oct4 expression (Abraham, Bronstein et al. 2013). It has been 
shown that reduced expression of Oct4 in hESCs promoted up-regulation of markers 
indicative of mesoderm and endoderm differentiation, while elevated levels of Oct4 in 
hESCs promoted up-regulation of markers indicative of endoderm derivatives 
(Rodriguez, Velkey et al. 2007). This could be one biological mechanism behind what 
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was is seen in the CyFIP1-/- EBs, where a massive expansion of the endoderm takes 
place, but mesoderm formation is decreased. Indeed, Oct4 is up-regulated at the 
mRNA level in CyFIP1-/- ES cells (data not shown). Another transcription factor, which 
is also important in embryonic development and was found to be up-regulated in 
CyFIP1-/- ES cells, is TGIF1. TGIF1 function is required for gastrulation, and limits the 
transcriptional response to Nodal signaling during early embryogenesis (Powers, 
Taniguchi et al. 2010). The nodal family of proteins belongs to the TGFβ superfamily 
and is responsible for meso-endoderm induction, patterning of the nervous system, 
and determination of dorsal- ventral axis in vertebrate embryos (Schier 2003). A third 
developmental transcription factor that was found up-regulated is RBBP7, which is also 
named retinoblastoma (Rb) suppressor-associated protein 46 (RbAp46). This factor 
plays an important role in negatively regulating -catenin expression and the -
catenin/TCF3 signaling pathway, presumably through regulation of GSK3 expression 
(Li and Wang 2006). RBBP7 is up-regulated in CyFIP1-/- ES cells and also in the EBs 
and may have an influence on the –catenin pathway, which is decreased in  
CyFIP1-/- EBs, although GSK3 protein levels in the mutant cells have not been verified 
yet. Atf4 a transcription factor that was also shown to regulate proliferation, blocking it 
when inhibited (Ye, Kumanova et al. 2010), was found significantly up-regulated in  
CyFIP1-/- ES cells. The only significantly down-regulated transcription factor found in 
CyFIP1-/- ES cells is RNF2, the Ring Finger Protein 2. This is an essential component 
of a Polycomb group (PcG) multi-protein PRC1-like complex, a complex class required 
to maintain the transcriptionally repressive state of many genes, including Hox genes, 
throughout development. The down-regulation of RNF2 could be the reason why Hox 
genes like TGIF1 and possibly also other transcription factors were up-regulated in the 
mutant ES cells. RNF2-deficient mice show a similar phenotype to the CyFIP1-/- mice 
(Voncken, Roelen et al. 2003). They are early embryonic lethal, don´t undergo normal 
gastrulation and have problems with mesoderm formation (Voncken, Roelen et al. 
2003).  
It seems that several unrelated genes belonging to different signaling pathways are 
affected by CyFIP1 depletion. There could be several explanation for this counter-
intuitive findings. One explanation could be that the effect of CyFIP1 depletion on the 
TGFβ pathway (discussed in 5.2) resulting in its down-regulation might imbalance the 
equilibrium between different and competitive pathways such as the PI3K and the 
MAPK pathways producing the described defects of the CyFIP1-/- ES cells. A second 
5. Discussion 
101 
 
possibility could be that in consequence of CyFIP1 depletion, one or more of the other 
WAVE complex subunits would be freed from the complex and therefore available to 
activate or inhibit other pathways. For example Abi1 is known to be in a tricomplex 
together with Eps8 and SOS1 (Innocenti, Tenca et al. 2002). Abi1 binds through its 
SH3 domain to the same binding site on SOS1 as Grb2, so that SOS1 can either form 
the tricomplex with Eps8 and Abi1 or form a functionally different Gbr2-SOS1 complex 
(Innocenti, Tenca et al. 2002). If Abi1 is freed from the WAVE complex due to the 
absence of CyFIP1 the complex with Gbr2 and SOS1 could not be formed in the correct 
amount because extra SOS1 would be sequestered in the tricomplex by the excess of 
available Abi1. All these hypotheses would have to be experimentally proved. 
Finally, CyFIP2 was found increased 1.5 fold in CyFIP1-/- cells by microarray analysis. 
CyFIP2 is a direct target of p53 (Jackson, Cho et al. 2007). It was shown that CyFIP2 
expression is sufficient to induce apoptotic cell death. The increase of CyFIP2 
expression could therefore explain the apoptosis phenotype of CyFIP1-/- ES cells and 
embryoid bodies. 
In conclusion CyFIP1 plays an important role in lineage determination by affecting 
developmental pathways that depend on TGF signaling, which explains the early 
failure of embryonic development. In this view CyFIP1 appears to regulate important 
cellular processes such as proliferation, adhesion, differentiation and apoptosis. 
 
 
5.4 CyFIP and the WAVE complex  
The classical WAVE complex consists of the five subunits CyFIP, Nap, WAVE, Abi, 
and HSPC300. Except for HSPC300, which has no known paralogues, each of the 
other subunits in mammals is a member of a protein family consisting of two or three 
paralogue genes, some of them also alternatively spliced. Considering all the different 
isoforms of each subunits, about 56 different WAVE complexes could be theoretically 
formed. Moreover, the new findings presented in this work suggest that the classical 
pentameric WAVE complex is only one possible complex. In fact in vivo a regulated 
exchange of subunits can occur. Under certain ionic conditions and in response to 
specific signaling the WAVE complex can break down. CyFIP and Nap appear to form 
a core complex around which the other subunits can assemble or not. When using a 
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physiological buffer rich in Mg2+, an intact pentameric WAVE complex binds to 
Profilin2. However, when divalent cations are completely sequestrated the WAVE 
complex falls apart uncoupling Abi1 and WAVE1 from the CyFIP/Nap1 core, 
suggesting that Mg2+ is an essential co-factor for integrity of the pentameric WAVE 
complex. In more physiological conditions, when phosphorylation is preserved, the 
binding of Cyfip1/2 and Nap1 to Profilin2 is significantly increased by about 5-fold, while 
binding of WAVE1 is reduced and retention of Abi1 is virtually abolished. This suggests 
that phosphorylation triggers CyFIP/Nap1 binding to Profilin2, and secondly that 
phosphorylation uncouples the other subunits from the CyFIP/Nap1 complex.  
Several conclusions can be drawn from the experiments presented in this work: first, 
different signals (phosphorylation, divalent ions) can control the stoichiometry of the 
WAVE complex in different ways. Secondly, phosphorylation appears to be a major 
regulatory mechanism of WAVE complex formation and subunit exchange. Finally, the 
results also prove that binding of the WAVE complex to Profilin2 occurs through the 
CyFIP/Nap1 core complex, directly or indirectly through another yet unidentified ligand. 
This explains how the WAVE complex in its full conformation can recruit Profilin2, when 
it is known that neither Abi nor WAVE when incorporated in the WAVE complex are 
able to bind to Profilin2, their PLP stretches being buried in the structure (Davidson 
and Insall 2013) (Insall, personal communication). 
These data are a fundamental finding in view of the other roles that the WAVE complex 
subunits might have in the cell and shed light on the possible interpretations of the 
CyFIP1 knockout phenotype. For example, phosphorylated Abi1 can activate PI3-
kinase by stabilizing the PI3-kinase regulatory p85 subunit and thereby trigger 
downstream signaling events via the PI3K/Akt pathway (Dubielecka, Machida et al. 
2010). However, a role of Abi1 phosphorylation for its incorporation in the WAVE 
complex has not been formally shown. In this view, it is possible that the stable 
CyFIP/Nap1 core complex can function to sequester the other subunits, thereby 
regulating the corresponding signaling pathways. The Chen et al. model of the WAVE 
complex structure suggests that activation of WAVE1 is basically mediated by a 
desequestration of the VCA-domain from CyFIP1 (Chen, Borek et al. 2010). The 
phenotype originated by the deletion of CyFIP1 and commented in the previous 
sections can therefore be also explained in this view. The reduction or complete 
depletion of the WAVE complex has freed the other subunits to activate without control 
other pathways, which have to be analyzed more in detail in the future. A similar 
5. Discussion 
103 
 
sequestration effect of the WAVE complex towards the Arp2/3 complex was described 
in a recent report where depletion of the WAVE complex in cells hyperactivated N-
WASP-Arp2/3-driven 3D migration (Tan, Li et al. 2013).  
In certain tissues the CyFIP/Nap1 complex might be differently regulated. As 
mentioned above, Profilin2 binds the classical WAVE complex with high efficiency from 
brain through the CyFIP/Nap1 core subunits. On the contrary, in kidney CyFIP and 
Nap1 are expressed, but no CyFIP/Nap1 complex could bind to Profilin2-beads. This 
leads to hypothesize the existence of a different modification of the WAVE complex in 
kidney or the presence of tissue-specific intermediary ligands. 
The diverse phenotypes of the knockout mouse models for the WAVE complex 
subunits also argue against a single common genetic pathway. Nap1 mutant embryos 
show a severe defect at E8.5 in axis polarity (Rakeman 2006), CyFIP1 mutants show 
early defects around E6.5 in mesodermal lineage formation, Abi1 mutants die around 
E11.5 because of vascularization defects (Ring, Ginsberg et al. 2011), while Abi2 
mutants are viable and show neuronal deficits (Grove, Demyanenko et al. 2004). 
WAVE1 mutants are viable (Soderling, Langeberg et al. 2003), but WAVE2 mutants 
die around E10.5 from angiogenesis defects (Yamazaki, Suetsugu et al. 2003). CyFIP2 
null mutants die at birth (Hauck, unpublished). Information on HSPC300/Brk1, WAVE3 
and Abi3 knockout mice are not available yet. This shows that in vivo the WAVE 
complex can serve quite distinct cellular pathways, although it is possible that the 
different subunits can compensate each other only in certain functions and cell types, 
but not others due to expression, splicing, or modification differences. Judging from 
the similar phenotypes, the mouse CyFIP1 and Nap1 genes and Abi1 and WAVE2 
genes seem to function in closely connected pathways and tissues. The genetic data 
from knockout studies suggest that in vivo a functional link between Cyfip1 and Nap1 
as well as Abi1 and WAVE2 exists, with the other subunits such as WAVE1 and 3, 
Abi2 and 3, and HSPC300/Brk1 having specific functions and possibly being 
exchangeable complex ligands. 
In summary the WAVE complex composition and complexity differs in tissues and 
cells. The WAVE complex that is bound to Profilin2 changes in response to different 
signaling pathways. The WAVE complex is not a stable pentameric complex, it 
undergoes dynamic turnover. 
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5.5 Infertility disorder of CyFIP1+/- females 
In this thesis work the novel infertility phenotype (POI) of CyFIP1 heterozygous 
females and a first evaluation of the morphological and biochemical features 
associated with the ovaries of CyFIP1+/- mice is described. The lower amount of 
CyFIP1 in the ovary leads to a down-regulation of the components of the WAVE 
complex, a higher number of atretic follicles and corpora lutea, and smaller antral and 
pre-ovulatory follicles. These findings provide a first insight into the early infertility 
phenotype of the CyFIP1 heterozygous females. Two potential mechanisms may be 
involved in the development of POI: (1) abnormalities in primordial follicle activation 
and (2) increased rates of apoptosis of oocytes (Sullivan and Castrillon 2011). The 
premutation of FMR1 is well known in the context of infertility disorders. A mouse model 
carrying the human FMR1 premutation allele showed that FMR1 premutation causes 
primary ovarian failure (Lu, Lin et al. 2012). FMR1 premutation RNA can cause a 
reduction in the number of growing follicles in ovaries and is sufficient to impair female 
fertility (Lu, Lin et al. 2012). In the CyFIP1-/- knockout a solid molecular phenotype 
seems to be a decreased signaling of the TGFβ pathway. Smad1/5 phosphorylation 
was significantly down-regulated in CyFIP1-/- ES cells. Interestingly, it has been shown 
that Smad1/5 play a key role also in female fertility. Double Smad1;Smad5 knockout 
females become infertile and develop metastatic granulosa cell tumors (Pangas, Li et 
al. 2008). The Anti-Mullerian Hormone (AMH) is also a member of the transforming 
growth factor-β (TGF-β) family and activates BMP-specific R-Smads (Smad 1, 5 and 
8) (di Clemente, Josso et al. 2003). In patients with primary ovarian failure, the Anti-
Mullerian Hormone is absent or reduced (Visser, Schipper et al. 2012). The AMH levels 
in CyFIP1+/- females have to be tested in future. In addition, the microarray results 
from CyFIP1-/- differentiated ES cells for 3 days on gelatine showed a significant up-
regulation of the transcription factor RHOX9, which is a member of the Reproductive 
Homeobox gene family and important in the reproductive system. RHOX9, together 
with RHOX5, was found to be expressed in follicular cells, is constitutively expressed 
in ovarian cells (Lee, Lee et al. 2013) and mRNA levels of RHOX9 were fairly 
consistently expressed during follicular development. RHOX9 knockout mice have no 
observable phenotype and ovulate normally (Takasaki, Rankin et al. 2001). So deletion 
of RHOX9 seems to be compensated by other RHOX genes (Takasaki, Rankin et al. 
2001). But overexpression may influence follicle development. RHOX9, also named 
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Gpbox (RHOXF1 in human), was discussed in a paper as a new candidate gene for 
premature ovarian failure (Suzumori, Pangas et al. 2007). 
From the biochemical point of view, POF1B was found by mass spectrometry as a new 
candidate ligand of the WAVE complex. Disrupted binding of POF1B (Premature 
Ovarian Failure Protein 1B) to non-muscle actin filaments is associated with premature 
ovarian failure (Lacombe, Lee et al. 2006). In human POF1B is located on the X 
chromosome, like FMR1, and these two genes have been formally demonstrated to be 
responsible for premature ovarian failure (Bione and Toniolo 2000). One additional 
possibility could be that the WAVE complex is regulating female fertility via its 
interaction with POF1B, which might also be part of the complex. Further experiments 
are needed to prove this hypothesis, as well as the TGF pathway down-regulation. 
In summary the heterozygous deletion of CyFIP1 shows similar effects on ovary 
function as the premutation of FMR1 and CyFIP1-mediated regulation of or CyFIP1 
interaction with genes important for follicle development and female fertility, such as 
RHOX9 and POF1B, could be relevant for the infertility phenotype of the CyFIP1+/- 
mouse. 
 
 
5.6 Conclusions and outlook 
The work presented in this thesis provides solid grounds to unravel the function of 
CyFIP1 and the WAVE complex in cells and during embryonic development. A novel 
and unexpected role of CyFIP1 in lineage determination via the TGF pathway was 
found, which explains the early failure of embryonic development. CyFIP1 is required 
during embryogenesis for mesodermal differentiation and has additional activities in 
controlling proliferation and adhesion. CyFIP1 also controls apoptosis and overall 
behaves as a tumor suppressor gene. 
In addition, in the female reproductive system of the mouse CyFIP1 plays a 
fundamental role and decreased CyFIP1 causes an infertility phenotype similar to a 
POF syndrome.  
Although CyFIP1 role as an actin nucleation promoting factor has been previously 
demonstrated, the knockout approach has shown that by itself or through the WAVE 
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complex it is indirectly regulating important signaling pathways, such as the TGFβ 
pathway.  
Finally, at the biochemical level the WAVE complex is not a stable pentameric complex, 
CyFIP/Nap1 build a core complex around which the other subunits assemble. Different 
signals (phosphorylation, divalent ions) can control the stoichiometry of the WAVE 
complex in different ways. Other proteins seem to interact with the WAVE complex, 
either due to its function in specific cellular processes (translational regulation, 
cargo/mRNA transport, signaling) or to allow its role in actin polymerization (for 
example in brain interacts with Profilin2 but not in kidney, where some other 
mechanism might be used) 
To address the open questions about CyFIP1 function further experiments will be 
needed. A reporter mouse line like a CyFIP1-LacZ insertion would be a helpful tool to 
characterize the distribution of CyFIP1 in the mouse tissues and to distinguish the 
different expression pattern of CyFIP1 and CyFIP2. A conditional CyFIP1 mouse 
model would be a great tool to analyze the function of CyFIP1 more specifically. The 
knockout of CyFIP1 in the brain would be very useful to distinguish the functions of 
CyFIP1 and CyFIP2 in the brain and to answer the question if they have overlapping 
functions or they act in completely different neuronal cell types or compartments. 
Electrophysiological analysis would address the question of synaptic and network 
physiology of neurons lacking CyFIP1. Specific knockout of CyFIP1 in neuronal 
subtypes would help to study the involvement of CyFIP1 in autism spectrum disorder.  
A further step would be the CyFIP1 and CyFIP2 double knockout mouse model for in 
vitro and/or in vivo studies. An interesting question is what would happen to the WAVE 
complex when there is no CyFIP at all: can the complex exist without CyFIP? What 
happens to the other components of the WAVE complex when they are freed from the 
WAVE complex due to CyFIP1 depletion? An interesting question is if in brain and 
kidney and perhaps other tissues have distinct from the classical WAVE complex other 
ligands and how would these complexes relate to actin nucleation.  
In conclusion in this work for the first time a molecular pathway was found, the TGFβ 
pathway, which consistently explains all the different phenotypes of CyFIP1 depletion 
(infertility of heterozygote females, embryonic development defects, cellular alterations 
such as proliferation, adhesion and apoptosis), although it is still missing the 
mechanism how CyFIP1 is affecting this signaling pathway. This will be the object of 
future studies. 
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Figure 38: Graphical representation of the surface area of the analyzed ovaries. Left: Ovaries from wt mice. 
Right: Ovaries from CyFIP1+/- mice. Grey columns: first ovary from the examined mouse. Black framed grey 
columns: second ovary from the examined mouse. The surface area varied strongly from mouse to mouse, 
independently of the genotype and no significant differences could be observed. 
 
 
Figure 39: Principal component analysis (PCA) mapping for the microarray data. The gene expression 
data after normalization for each genotype and time point are represented by circles of different color. Each 
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colored circle represents data from one clone. wt-0 green: Wild type ES cells; ko-0 red: CyFIP1-/- ES cells; wt-3 
purple: Differentiated wild type ES cells for 3 days on gelatine; ko-3 blue: Differentiated CyFIP1-/- ES cells for 3 
days on gelatine. The three clones for each type show very little variance, therefore a mean of the three could 
be used for further analyses. 
 
